Plant ID: NPO21334
Plant Latin Name: Artemisia Dracunculus
Taxonomy Genus: Artemisia
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
72341
Plant-of-the-World-Online:
n.a.
Antiscorbutic; Appetizer; Diuretic; Emmenagogue; Febrifuge; Hypnotic; Odontalgic; Stomachic; Vermifuge
Switzerland; India; China
Ingredient ID: NPC99734
Ingredient ID: NPC94167
Ingredient ID: NPC92943
Ingredient ID: NPC92869
Ingredient ID: NPC91475
Ingredient ID: NPC90486
Ingredient ID: NPC85210
Ingredient ID: NPC83187
Ingredient ID: NPC74539
Ingredient ID: NPC74384
Ingredient ID: NPC73980
Ingredient ID: NPC72042
Ingredient ID: NPC71853
Ingredient ID: NPC71339
Ingredient ID: NPC70691
Ingredient ID: NPC65134
Ingredient ID: NPC60173
Ingredient ID: NPC55412
Ingredient ID: NPC53559
Ingredient ID: NPC502
Ingredient ID: NPC49074
Ingredient ID: NPC489907
Ingredient ID: NPC474157
Ingredient ID: NPC46634
Ingredient ID: NPC46254
Ingredient ID: NPC43246
Ingredient ID: NPC38742
Ingredient ID: NPC38212
Ingredient ID: NPC33415
Ingredient ID: NPC32991
Ingredient ID: NPC32441
Ingredient ID: NPC312800
Ingredient ID: NPC31279
Ingredient ID: NPC312132
Ingredient ID: NPC311783
Ingredient ID: NPC311255
Ingredient ID: NPC31090
Ingredient ID: NPC308744
Ingredient ID: NPC302857
Ingredient ID: NPC29883
Ingredient ID: NPC296071
Ingredient ID: NPC294902
Ingredient ID: NPC292792
Ingredient ID: NPC28828
Ingredient ID: NPC287331
Ingredient ID: NPC283170
Ingredient ID: NPC279121
Ingredient ID: NPC279026
Ingredient ID: NPC272524
Ingredient ID: NPC269919
Ingredient ID: NPC269242
Ingredient ID: NPC269023
Ingredient ID: NPC265305
Ingredient ID: NPC264784
Ingredient ID: NPC263089
Ingredient ID: NPC261644
Ingredient ID: NPC259134
Ingredient ID: NPC258476
Ingredient ID: NPC257124
Ingredient ID: NPC252587
Ingredient ID: NPC2517
Ingredient ID: NPC251666
Ingredient ID: NPC247553
Ingredient ID: NPC246558
Ingredient ID: NPC246165
Ingredient ID: NPC244315
Ingredient ID: NPC240722
Ingredient ID: NPC239039
Ingredient ID: NPC235260
Ingredient ID: NPC235190
Ingredient ID: NPC232375
Ingredient ID: NPC232141
Ingredient ID: NPC230775
Ingredient ID: NPC225709
Ingredient ID: NPC216825
Ingredient ID: NPC214971
Ingredient ID: NPC210456
Ingredient ID: NPC210092
Ingredient ID: NPC209632
Ingredient ID: NPC20791
Ingredient ID: NPC205649
Ingredient ID: NPC204388
Ingredient ID: NPC202992
Ingredient ID: NPC201844
Ingredient ID: NPC200838
Ingredient ID: NPC195355
Ingredient ID: NPC191103
Ingredient ID: NPC19003
Ingredient ID: NPC187770
Ingredient ID: NPC182840
Ingredient ID: NPC182468
Ingredient ID: NPC181715
Ingredient ID: NPC179987
Ingredient ID: NPC17810
Ingredient ID: NPC176819
Ingredient ID: NPC176740
Ingredient ID: NPC176309
Ingredient ID: NPC175771
Ingredient ID: NPC173996
Ingredient ID: NPC172625
Ingredient ID: NPC167400
Ingredient ID: NPC163984
Ingredient ID: NPC157340
Ingredient ID: NPC152384
Ingredient ID: NPC150950
Ingredient ID: NPC147983
Ingredient ID: NPC145463
Ingredient ID: NPC13990
Ingredient ID: NPC138113
Ingredient ID: NPC137949
Ingredient ID: NPC13755
Ingredient ID: NPC13449
Ingredient ID: NPC13304
Ingredient ID: NPC13143
Ingredient ID: NPC130306
Ingredient ID: NPC125085
Ingredient ID: NPC125062
Ingredient ID: NPC117299
Ingredient ID: NPC116775
Ingredient ID: NPC115919
Ingredient ID: NPC114594
Ingredient ID: NPC111888
Ingredient ID: NPC111690
Ingredient ID: NPC110899
Ingredient ID: NPC104190
Ingredient ID: NPC100773
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 | Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 | Cytochrome P450 family 2 | CYP2B6 | Cytochrome P450 2B6 | P20813 | CHEMBL4729 |
Therapeutic Target | Enzyme | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Therapeutic Target | Enzyme | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Therapeutic Target | Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Therapeutic Target | Hydrolase | CDA | Cytidine deaminase | P32320 | CHEMBL4502 |
Therapeutic Target | Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Therapeutic Target | Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Therapeutic Target | Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Therapeutic Target | Membrane receptor | APP | Beta amyloid A4 protein | P05067 | CHEMBL2487 |
Therapeutic Target | Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
Therapeutic Target | Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Therapeutic Target | Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Therapeutic Target | Metallo protease | MMP12 | Matrix metalloproteinase 12 | P39900 | CHEMBL4393 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Therapeutic Target | Other cytosolic protein | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Therapeutic Target | Oxidoreductase | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Therapeutic Target | Oxidoreductase | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Therapeutic Target | Oxidoreductase | AOX1 | Aldehyde oxidase | Q06278 | CHEMBL3257 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Therapeutic Target | Protein Kinase | AURKB | Serine/threonine-protein kinase Aurora-B | Q96GD4 | CHEMBL2185 |
Therapeutic Target | Protein Kinase | CDK1 | Cyclin-dependent kinase 1 | P06493 | CHEMBL308 |
Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Therapeutic Target | Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
Therapeutic Target | Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Therapeutic Target | Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Therapeutic Target | Protein Kinase | AXL | Tyrosine-protein kinase receptor UFO | P30530 | CHEMBL4895 |
Therapeutic Target | Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
Therapeutic Target | Protein Kinase | YES1 | Tyrosine-protein kinase YES | P07947 | CHEMBL2073 |
Therapeutic Target | Protein Kinase | IGF1R | Insulin-like growth factor I receptor | P08069 | CHEMBL1957 |
Therapeutic Target | Protein Kinase | MKNK1 | MAP kinase-interacting serine/threonine-protein kinase MNK1 | Q9BUB5 | CHEMBL4718 |
Therapeutic Target | Protein Kinase | MKNK2 | MAP kinase signal-integrating kinase 2 | Q9HBH9 | CHEMBL4204 |
Therapeutic Target | Serine protease | DPP4 | Dipeptidyl peptidase IV | P27487 | CHEMBL284 |
Drug Transporter | SLC superfamily of solute carriers | SLC6A4 | Serotonin transporter | P31645 | CHEMBL228 |
Drug Transporter | SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Drug Transporter | SLC superfamily of solute carriers | SLC6A2 | Norepinephrine transporter | P23975 | CHEMBL222 |
Drug Transporter | SLC superfamily of solute carriers | SLC6A3 | Dopamine transporter | Q01959 | CHEMBL238 |
Therapeutic Target | Small molecule receptor (family A GPCR) | DRD1 | Dopamine D1 receptor | P21728 | CHEMBL2056 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADRA2B | Alpha-2b adrenergic receptor | P18089 | CHEMBL1942 |
Therapeutic Target | Small molecule receptor (family A GPCR) | HCAR2 | Hydroxycarboxylic acid receptor 2 | Q8TDS4 | CHEMBL3785 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Transcription factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Therapeutic Target | Transcription factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Therapeutic Target | Transcription factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Therapeutic Target | Transferase | TK1 | Thymidine kinase, cytosolic | P04183 | CHEMBL2883 |
Therapeutic Target | Transferase | SULT1A1 | Sulfotransferase 1A1 | P50225 | CHEMBL1743291 |
Therapeutic Target | Unclassified protein | SNCA | Alpha-synuclein | P37840 | CHEMBL6152 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 996 | |
Plant level | 1 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | colorectal neoplasm | Folic Acid (NPC147983) | NP level |
NCT00003667 | Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma | sarcoma | Glycerin (NPC157340) | NP level |
NCT01319734 | Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Ascorbate (NPC187770) | NP level |
NCT03797443 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
NCT03680274 | Lessening Organ Dysfunction With VITamin C | COVID-19;Sepsis | Ascorbate (NPC187770) | NP level |
NCT00892073 | Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy | obesity | Metformin (NPC230775) | NP level |
NCT04500756 | Limiting AAA With Metformin (LIMIT) Trial | Abdominal Aortic Aneurysm | Metformin (NPC230775) | NP level |
NCT02285855 | Metformin in Non Small Cell Lung Cancer (NSCLC) | lung cancer | Metformin (NPC230775) | NP level |
NCT02981329 | Fetal Hemoglobin Induction Treatment Metformin | sickle cell anemia | Metformin (NPC230775) | NP level |
NCT00856284 | Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00900146 | Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01089166 | Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting Condition | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00578305 | A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00054938 | Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) | systemic lupus erythematosus | Folic Acid (NPC147983) | NP level |
NCT02018731 | L-citrulline and Metformin in Becker's Muscular Dystrophy | muscular dystrophy | Metformin (NPC230775) | NP level |
NCT00106340 | Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00005025 | Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Thymidine (NPC71339) | NP level |
NCT03490019 | Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement | Bardet-Biedl syndrome;blindness (disorder) | Metformin (NPC230775) | NP level |
NCT00337610 | Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01375101 | Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus | oral lichen planus | Quercetin (NPC20791) | NP level |
NCT03410030 | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | pancreatic ductal adenocarcinoma | Ascorbate (NPC187770) | NP level |
NCT01014546 | Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis | essential thrombocythemia;polycythemia vera;primary myelofibrosis | Ascorbate (NPC187770) | NP level |
NCT01796028 | Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer | prostate adenocarcinoma | Metformin (NPC230775) | NP level |
NCT01154348 | Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02086526 | Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT03670043 | Tolerance & Responsiveness Improvement for Metformin (TRIM) | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03697239 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Ascorbate (NPC187770) | NP level |
NCT03072485 | Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers | aging | Metformin (NPC230775) | NP level |
NCT03799094 | Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
NCT02815397 | DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma | diffuse large B-cell lymphoma | Metformin (NPC230775) | NP level |
NCT00121641 | Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00703196 | Folic Acid Clinical Trial for the Prevention of Cervical Cancer | cervical cancer | Folic Acid (NPC147983) | NP level |
NCT00316758 | A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00344851 | Exenatide and Metformin Therapy in Overweight Women With PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00744367 | A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02143050 | Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients | melanoma | Metformin (NPC230775) | NP level |
NCT00414245 | Metformin for the Treatment of Diabetes in Pregnancy | gestational diabetes;type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05363917 | Natrunix Versus Methotrexate in Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00103857 | MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04098666 | Metformin in Alzheimer's Dementia Prevention | Cognitive impairment | Metformin (NPC230775) | NP level |
NCT00000512 | Familial Atherosclerosis Treatment Study | Myocardial Ischemia | Niacin (NPC167400) | NP level |
NCT00454233 | A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02226484 | Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? | gastroesophageal reflux disease | Quercetin (NPC20791) | NP level |
NCT01472367 | A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00605475 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00631111 | Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain | pain | Ascorbate (NPC187770) | NP level |
NCT03268733 | The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome | polycystic ovary syndrome | Folic Acid (NPC147983) | NP level |
NCT00944645 | MK0524A Bioequivalence Study (0524A-059) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT03989271 | Biological Effects of Quercetin in COPD | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT02521077 | Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer | Fatigue | Ascorbate (NPC187770) | NP level |
NCT03592693 | Vitamin C, Hydrocortisone and Thiamine for Septic Shock | septic shock | Ascorbate (NPC187770) | NP level |
NCT01083329 | Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects | obesity | Niacin (NPC167400) | NP level |
NCT04989049 | Therapeutic Effect of Folic Acid in Healing of Oral Ulcers | Oral ulcer | Folic Acid (NPC147983) | NP level |
NCT02318446 | Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics | epilepsy | Folic Acid (NPC147983) | NP level |
NCT00000114 | Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa | retinitis pigmentosa | Retinol (NPC55412) | NP level |
NCT00701090 | A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01135433 | A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00789191 | Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01785186 | Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design | tuberculosis | Pyridoxine (NPC269919) | NP level |
NCT02629627 | Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
NCT01192152 | Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02833701 | Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
NCT04354428 | Treatment for COVID-19 in High-Risk Adult Outpatients | COVID-19 | Folic Acid (NPC147983);Ascorbate (NPC187770) | NP level |
NCT00772174 | Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02394652 | The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial | cervical adenocarcinoma;squamous cell carcinoma | Metformin (NPC230775) | NP level |
NCT01205672 | Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
NCT00004758 | Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment | epilepsy | Pyridoxine (NPC269919) | NP level |
NCT01289119 | Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00856986 | The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02684578 | Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD | atrophic macular degeneration | Metformin (NPC230775) | NP level |
NCT03824002 | Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05243654 | Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy | leprosy | Metformin (NPC230775) | NP level |
NCT04068246 | The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients | rheumatoid arthritis | Metformin (NPC230775) | NP level |
NCT04649502 | Metformin for the Treatment of Hidradenitis Suppurativa (HS) | hidradenitis suppurativa | Metformin (NPC230775) | NP level |
NCT02420314 | Pharmacological Ascorbate for Lung Cancer | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
NCT01890122 | Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02848508 | Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study | chronic kidney disease | Metformin (NPC230775) | NP level |
NCT02990728 | Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
NCT03710343 | Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study | spastic cerebral palsy | Metformin (NPC230775) | NP level |
NCT03056274 | Metformin in Intrahepatic Cholestasis of Pregnancy | pregnancy | Metformin (NPC230775) | NP level |
NCT03617458 | Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Metformin (NPC230775) | NP level |
NCT00855166 | Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00698789 | Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04631536 | Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC | COVID-19 | Folic Acid (NPC147983) | NP level |
NCT01733459 | Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT04148183 | Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients. | insulin resistance | Metformin (NPC230775) | NP level |
NCT00619203 | Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis | bacterial meningitis | Glycerin (NPC157340) | NP level |
NCT01529593 | Temsirolimus in Combination With Metformin in Patients With Advanced Cancers | cancer | Metformin (NPC230775) | NP level |
NCT01750567 | A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL | chronic lymphocytic leukemia | Metformin (NPC230775) | NP level |
NCT01296412 | Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02254512 | Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) | carcinoma | Metformin (NPC230775) | NP level |
NCT03243851 | Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma | glioblastoma multiforme | Metformin (NPC230775) | NP level |
NCT02083692 | Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling | squamous cell carcinoma | Metformin (NPC230775) | NP level |
NCT03117517 | Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00903617 | Study to Test GSK256073 in Patients With Dyslipidemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT02780505 | Assessment of the Effect of Vitamin C on Anemia in Patients With Continuous Ambulatory Peritoneal Dialysis | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
NCT02930343 | Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00384293 | Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) | familial hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT01926769 | A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer | colorectal adenocarcinoma | Metformin (NPC230775) | NP level |
NCT02028221 | Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk | breast cancer | Metformin (NPC230775) | NP level |
NCT03349775 | Cardiometabolic Disease and Pulmonary Hypertension | obesity | Metformin (NPC230775) | NP level |
NCT00329498 | L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | acute myeloid leukemia;myelodysplastic syndrome | Ascorbate (NPC187770) | NP level |
NCT04170959 | The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT03000218 | Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems | Elevated hepatic transaminase;obesity | Metformin (NPC230775) | NP level |
NCT01708278 | Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT00111891 | An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT03378297 | IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC | ovarian cancer | Metformin (NPC230775) | NP level |
NCT00703755 | A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome. | metabolic syndrome | Metformin (NPC230775) | NP level |
NCT00069836 | Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00000541 | Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) | myocardial infarction | Ascorbate (NPC187770);Folic Acid (NPC147983);Pyridoxine (NPC269919);Beta Carotene (NPC17810) | NP level |
NCT02402348 | Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis | head and neck malignant neoplasia | Metformin (NPC230775) | NP level |
NCT03179254 | Type 2 Diabetes and Ambulatory Surgery Patients | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | colorectal carcinoma | Folic Acid (NPC147983);Ascorbate (NPC187770) | NP level |
NCT03086733 | Phase II Lung Metcore - Preoperative Metformin for Lung Cancer | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT03751592 | Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer | lung cancer | Chlorogenic Acid (NPC302857) | NP level |
NCT02083575 | Role of Vitamin C to Augment Iron Chelation With DFP or DFX | beta-thalassemia major | Ascorbate (NPC187770) | NP level |
NCT00969566 | Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02614859 | Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients | prostate carcinoma | Metformin (NPC230775) | NP level |
NCT05305898 | "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome | acute coronary syndrome | Metformin (NPC230775) | NP level |
NCT00283816 | Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT03135301 | Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome | infertility | Metformin (NPC230775) | NP level |
NCT02279758 | A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors | neuroendocrine neoplasm | Metformin (NPC230775) | NP level |
NCT00960661 | A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04370288 | Clinical Application of Methylene Blue for Treatment of Covid-19 Patients | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT04334512 | A Study of Quintuple Therapy to Treat COVID-19 Infection | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT00536510 | Effect of MK0524A on Cholesterol Levels (0524A-048) | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
NCT00575588 | 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02908581 | Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis | heavy metal poisoning | Folic Acid (NPC147983) | NP level |
NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | gastric cancer | Ascorbate (NPC187770) | NP level |
NCT03828929 | Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock | septic shock | Ascorbate (NPC187770) | NP level |
NCT00533195 | Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis | atopic eczema | Bergapten (NPC74539) | NP level |
NCT01442870 | Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy | cancer | Metformin (NPC230775) | NP level |
NCT00770835 | Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01061736 | Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT02848131 | Senescence in Chronic Kidney Disease | chronic kidney disease | Quercetin (NPC20791) | NP level |
NCT01995032 | L-citrulline and Metformin in Duchenne's Muscular Dystrophy | muscular dystrophy | Metformin (NPC230775) | NP level |
NCT04530058 | The Effects of Metformin on Morbidity and Mortality in Elderly Patients | burn | Metformin (NPC230775) | NP level |
NCT00943124 | MK0524B Bioequivalence Study (0524B-070) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT01915550 | Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01318135 | Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00000116 | Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A | retinitis pigmentosa | Retinol (NPC55412) | NP level |
NCT00838903 | Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00396500 | Deworming and Vitamin A (DEVTA) Prepilot Study | malnutrition;parasitic infection | Retinol (NPC55412) | NP level |
NCT00754689 | Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03943459 | Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT00960076 | An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00975052 | A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02516085 | Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin | Duchenne muscular dystrophy | Metformin (NPC230775) | NP level |
NCT00034463 | ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer | cancer | Folic Acid (NPC147983) | NP level |
NCT00332488 | Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01474499 | A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation | Constipation | Glycerin (NPC157340) | NP level |
NCT05053841 | Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women | breast cancer | Metformin (NPC230775) | NP level |
NCT04853199 | Quercetin In The Treatment Of SARS-COV 2 | COVID-19 | Quercetin (NPC20791) | NP level |
NCT03450707 | Thiamine as a Metabolic Resuscitator After Cardiac Arrest | cardiac arrest | Thiamine (NPC150950) | NP level |
NCT00950989 | Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT04925063 | The Effect of Metformin in Patients With Newly Diagnosed mHSPC | metastatic prostate cancer | Metformin (NPC230775) | NP level |
NCT00359112 | AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04516681 | IV Ascorbic Acid in Peritoneal Metastatic Colorectal Cancer | colorectal carcinoma | Ascorbate (NPC187770) | NP level |
NCT00499707 | Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00613951 | Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03006172 | To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT00798161 | Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01587963 | High Dose Vitamin C in the Critically Ill Patient | Shock | Ascorbate (NPC187770) | NP level |
NCT00388856 | Antioxidant Supplementation in Pregnant Women With Low Antioxidant Status | preeclampsia | Ascorbate (NPC187770) | NP level |
NCT01583647 | A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) | familial hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT00598793 | Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04357782 | Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation | hypoxia;COVID-19 | Ascorbate (NPC187770) | NP level |
NCT00032487 | Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00690456 | Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01775176 | Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00781196 | Folic Acid Supplementation in Phenytoin Induced Gingival Overgrowth | gingival overgrowth | Folic Acid (NPC147983) | NP level |
NCT03465345 | Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients | prostate cancer | Metformin (NPC230775) | NP level |
NCT01580683 | Vitamin C and Atrial Fibrillation After Cardiac Surgery | atrial fibrillation | Ascorbate (NPC187770) | NP level |
NCT01357876 | Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01204775 | Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00263276 | A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01587261 | Vitamin C for Severe Thermal Injuries | injury | Ascorbate (NPC187770) | NP level |
NCT00081328 | Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00279045 | Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00789035 | 12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01864096 | The Metformin Active Surveillance Trial (MAST) Study | prostate cancer | Metformin (NPC230775) | NP level |
NCT04792749 | Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
NCT00611884 | Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01581814 | Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01908452 | Pyridoxal Kinase Activity in Tardive Dyskinesia | movement disorder | Pyridoxine (NPC269919) | NP level |
NCT00300365 | Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL | metabolic syndrome | Niacin (NPC167400) | NP level |
NCT02048761 | Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
NCT02730364 | An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu | respiratory tract infectious disorder | Ascorbate (NPC187770) | NP level |
NCT00202280 | Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication | psychosis | Folic Acid (NPC147983);Pyridoxine (NPC269919) | NP level |
NCT00071266 | The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC | intermittent vascular claudication | Niacin (NPC167400) | NP level |
NCT03238495 | Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT01590303 | Outcome Following Vitamin C Administration in Sepsis | Sepsis | Ascorbate (NPC187770) | NP level |
NCT02602483 | Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD). | temporomandibular joint disorder | Ascorbate (NPC187770) | NP level |
NCT02848950 | The Effect of Metformin on Fecundability in an ART(Assisted Reproductive Technology) Setting - the Correlation to Uterine Flows | infertility | Metformin (NPC230775) | NP level |
NCT01194453 | Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
NCT01840007 | Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma | metastatic melanoma | Metformin (NPC230775) | NP level |
NCT02106650 | Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies | unspecified peripheral T-cell lymphoma | Folic Acid (NPC147983) | NP level |
NCT02189772 | Safety and Tolerability Study of Metadoxine Extended Release (MDX) (Previously Known as MG01CI) in PI-ADHD Adolescent Subjects | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
NCT02614339 | Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal Cancer | colorectal carcinoma | Metformin (NPC230775) | NP level |
NCT01217073 | A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01046422 | Safety Study of BMS-770767 in Subjects With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00333151 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01555489 | Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
NCT05093959 | Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction Pilot Study | heart failure | Metformin (NPC230775) | NP level |
NCT02800161 | Trehalose as add-on Therapy in Bipolar Depression | bipolar disorder | Maltose (NPC246558) | NP level |
NCT00397917 | Oral Cleft Prevention Program | cleft lip;Cleft palate | Folic Acid (NPC147983) | NP level |
NCT02114502 | Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma | multiple myeloma | Pyridoxine (NPC269919) | NP level |
NCT00065455 | Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa | retinitis pigmentosa | Retinol (NPC55412) | NP level |
NCT00672386 | A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00272064 | ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05029037 | High-dose Intravenous Vitamin C (HDIVC) as Adjuvant Therapy in Critical Patients With Positive COVID-19. A Pilot Randomized Controlled Dose-comparison Trial. | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT04865835 | A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. | schizophrenia | Metformin (NPC230775) | NP level |
NCT04401150 | Lessening Organ Dysfunction With VITamin C - COVID-19 | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT01059825 | Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00743002 | A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00374907 | A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01352026 | Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH) | pulmonary arterial hypertension | Metformin (NPC230775) | NP level |
NCT04767841 | The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis | osteoarthritis | Metformin (NPC230775) | NP level |
NCT05378919 | Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer | rectum cancer | Folic Acid (NPC147983) | NP level |
NCT02701673 | Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma | lymphoma | Pyridoxine (NPC269919) | NP level |
NCT00279240 | Life Style Modifications Prevents Type 2 Diabetes in Asian Indians | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00120822 | Folic Acid Supplementation in Gambian Primigravidae | malaria | Folic Acid (NPC147983) | NP level |
NCT00000152 | Randomized Trial of Beta-Carotene and Macular Degeneration | macular degeneration | Beta Carotene (NPC17810) | NP level |
NCT02696941 | SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis | non-alcoholic fatty liver disease | Metformin (NPC230775) | NP level |
NCT04177303 | Incretin Hormones in Type 1 Diabetes Mellitus | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02631668 | the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
NCT00102466 | Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00067899 | Oxidative Stress and Vitamin E Requirements | nicotine dependence | Ascorbate (NPC187770) | NP level |
NCT02488564 | A Study of Liposomal Doxorubicin + Docetaxel + Trastuzumab + Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT04275713 | Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC | cervical cancer | Metformin (NPC230775) | NP level |
NCT05440591 | Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02390505 | Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery | complex regional pain syndrome | Ascorbate (NPC187770) | NP level |
NCT01996696 | Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate | prostate adenocarcinoma | Metformin (NPC230775) | NP level |
NCT03862950 | A Trial of Metformin in Individuals With Fragile X Syndrome (Met) | fragile X syndrome;intellectual disability;Intellectual disability;neurobehavioral manifestations;sex chromosome disorder of sex development | Metformin (NPC230775) | NP level |
NCT01911247 | Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer | endometrial cancer | Metformin (NPC230775) | NP level |
NCT01804049 | Metformin and Muscle in Insulin-resistant Older Veterans | prediabetes syndrome | Metformin (NPC230775) | NP level |
NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | atherosclerosis;coronary artery disease;Hypercholesterolemia;hypertension;type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04607252 | Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia | endometrial hyperplasia | Metformin (NPC230775) | NP level |
NCT02044341 | Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media | Otitis media | Glycerin (NPC157340) | NP level |
NCT02115464 | Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy | lung cancer | Metformin (NPC230775) | NP level |
NCT00763633 | B6 Treatment for Nausea and Vomiting in Pregnancy | Nausea and vomiting | Pyridoxine (NPC269919) | NP level |
NCT00734695 | Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment. | burn | Ascorbate (NPC187770) | NP level |
NCT03516903 | Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI | myocardial infarction | Folic Acid (NPC147983) | NP level |
NCT03600363 | A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients | diffuse large B-cell lymphoma;follicular lymphoma | Metformin (NPC230775) | NP level |
NCT03039075 | Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00620191 | Metformin in Amnestic Mild Cognitive Impairment | Cognitive impairment | Metformin (NPC230775) | NP level |
NCT02606773 | "Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects | ascorbic acid deficiency | Ascorbate (NPC187770) | NP level |
NCT02136342 | Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer | cancer | Chlorogenic Acid (NPC302857) | NP level |
NCT01118624 | Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer | breast carcinoma | Folic Acid (NPC147983) | NP level |
NCT03758014 | Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients | glioblastoma multiforme | Chlorogenic Acid (NPC302857) | NP level |
NCT01051011 | A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01050621 | Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective | cancer | Ascorbate (NPC187770) | NP level |
NCT00859898 | Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01068730 | Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01632020 | Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth | colorectal neoplasm | Metformin (NPC230775) | NP level |
NCT05468554 | Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer | thyroid cancer | Metformin (NPC230775) | NP level |
NCT00634998 | Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy | diabetic neuropathy | Ascorbate (NPC187770) | NP level |
NCT01561482 | Study of Metformin With Simvastatin for Men With Prostate Carcinoma | prostate carcinoma | Metformin (NPC230775) | NP level |
NCT00975286 | 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00479466 | Dose-Range Finding Study for MK0893 (0893-008) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05284656 | Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease | chronic kidney disease | Folic Acid (NPC147983) | NP level |
NCT03477162 | Metformin Pharmacology in Human Cancers: A Proof of Principle Study | neoplasm of thorax | Metformin (NPC230775) | NP level |
NCT02844803 | Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03204058 | Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
NCT00672360 | Folate Rechallenge | autism | Folic Acid (NPC147983) | NP level |
NCT01685762 | Metformin for the Treatment of Endometrial Hyperplasia | endometrial hyperplasia | Metformin (NPC230775) | NP level |
NCT02275845 | Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
NCT01188876 | Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Folic Acid (NPC147983) | NP level |
NCT00885378 | Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02562664 | Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT03054519 | Improve PAD PERformance With METformin | peripheral arterial disease | Metformin (NPC230775) | NP level |
NCT03602235 | High Dose Ascorbic Acid for Plasma Cell Disorders | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT03964688 | Effect of Vitamin C in Autologous Stem Cell Transplantations | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT00271635 | Ascorbic Acid Treatment in CMT1A Trial (AATIC) | Charcot-Marie-Tooth disease | Ascorbate (NPC187770) | NP level |
NCT02762838 | Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00995085 | Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
NCT04817787 | Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
NCT00033722 | Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | lung cancer | Folic Acid (NPC147983) | NP level |
NCT04999137 | Evaluation of Safety and Dosing of a Vitamin C Bundle for Sepsis Treatment in Africa | Sepsis;septic shock | Ascorbate (NPC187770) | NP level |
NCT00063635 | Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) | Hepatic steatosis | Metformin (NPC230775) | NP level |
NCT05009355 | The Effect of Vitamin C on GCF Total Oxidant Capacity in Smoker Patients With Periodontitis | ascorbic acid deficiency | Ascorbate (NPC187770) | NP level |
NCT00062556 | Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication | intermittent vascular claudication | Niacin (NPC167400) | NP level |
NCT02325401 | Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck malignant neoplasia | Metformin (NPC230775) | NP level |
NCT01828437 | Addition of Pyridoxine to Prednisolone in Infantile Spasms | West syndrome | Pyridoxine (NPC269919) | NP level |
NCT02019979 | Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT02473094 | Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer | rectum cancer | Metformin (NPC230775) | NP level |
NCT05373680 | Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression | chronic kidney disease | Metformin (NPC230775) | NP level |
NCT03540758 | Regulation of Endogenous Glucose Production by Central KATP Channels | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
NCT01983969 | Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma | cancer;lymphoma | Pyridoxine (NPC269919) | NP level |
NCT02672488 | Metformin Plus Sorafenib for Advanced HCC | hepatocellular carcinoma | Metformin (NPC230775) | NP level |
NCT04268849 | Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient | Iron deficiency anemia | Ascorbate (NPC187770) | NP level |
NCT00754988 | A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01089179 | Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed Conditions | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00961857 | A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00317811 | Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT04395768 | International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT01396564 | Pioglitazone and Metformin in Diabetic Children | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02109315 | Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. | type 1 diabetes mellitus | Ascorbate (NPC187770) | NP level |
NCT00000600 | Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up | carotid artery disease;cerebral atherosclerosis;heart disease | Ascorbate (NPC187770) | NP level |
NCT03172325 | Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT04035096 | The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients | malignant colon neoplasm | Ascorbate (NPC187770) | NP level |
NCT00930579 | Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation | breast cancer | Metformin (NPC230775) | NP level |
NCT04648917 | GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC) | esophageal cancer | Caffeic Acid (NPC294902) | NP level |
NCT02903511 | Feasibility Study of Metformin Therapy in ADPKD | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
NCT01984073 | Effects of Niacin On Fatty Acid Trapping | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT04347889 | Preventing COVID-19 in Healthcare Workers With HCQ: A RCT | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT00528879 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00728351 | Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01340664 | An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03311308 | A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma | melanoma | Metformin (NPC230775) | NP level |
NCT01243242 | Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD) | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
NCT02040376 | Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma | brain neoplasm | Metformin (NPC230775) | NP level |
NCT01365091 | Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00133419 | Micronutrients and Enteric Infections in African Children | infection | Retinol (NPC55412) | NP level |
NCT02312661 | Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer | ovarian cancer | Metformin (NPC230775) | NP level |
NCT04328961 | Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT01816659 | An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin | colorectal carcinoma | Metformin (NPC230775) | NP level |
NCT01134341 | Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma | anaplastic large cell lymphoma;mycosis fungoides;Sezary's disease | Folic Acid (NPC147983) | NP level |
NCT00121667 | Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00528372 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00000555 | Women's Angiographic Vitamin and Estrogen Trial (WAVE) | menopause;Myocardial Ischemia | Ascorbate (NPC187770) | NP level |
NCT03066115 | Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow Regulation | hypoxia | Ascorbate (NPC187770) | NP level |
NCT00469586 | Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00284427 | Safety of Antioxidants During GYN Cancer Care | cervical cancer;ovarian cancer | Ascorbate (NPC187770) | NP level |
NCT01336322 | Metformin and Sitagliptin in Women With Previous Gestational Diabetes | prediabetes syndrome | Metformin (NPC230775) | NP level |
NCT02678234 | An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu | respiratory tract infectious disorder | Ascorbate (NPC187770) | NP level |
NCT00468039 | A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00727857 | Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04839237 | The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients | obesity | Metformin (NPC230775) | NP level |
NCT00871936 | A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03508726 | High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas | soft tissue sarcoma | Ascorbate (NPC187770) | NP level |
NCT00266227 | A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT01310231 | A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT01370707 | A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00024310 | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Folic Acid (NPC147983) | NP level |
NCT02360059 | Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT01111955 | Safety Study of BMS-823778 in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00796887 | Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery | Ischemic stroke | Niacin (NPC167400) | NP level |
NCT00184054 | Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia | acute myeloid leukemia | Ascorbate (NPC187770) | NP level |
NCT02497638 | LIpitor and biGuanide to Androgen Delay Trial | prostate cancer | Metformin (NPC230775) | NP level |
NCT00643851 | An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01613755 | Metformin-Dipyridamole Interaction Trial | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02278965 | Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer | breast carcinoma in situ | Metformin (NPC230775) | NP level |
NCT01076075 | A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00271817 | To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT01084486 | Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease | non-alcoholic fatty liver disease | Metformin (NPC230775) | NP level |
NCT01332071 | Avandamet Bioequivalence Study Brazil - Fed Administration | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04261036 | Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries | urinary tract infection | Ascorbate (NPC187770) | NP level |
NCT00318461 | To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03752918 | The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. | post-traumatic stress disorder | Niacin (NPC167400) | NP level |
NCT03889795 | Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors | pancreatic carcinoma | Metformin (NPC230775) | NP level |
NCT00383578 | Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04511416 | Preventing Cognitive Decline With Metformin | Mental deterioration | Metformin (NPC230775) | NP level |
NCT02149459 | Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy | brain neoplasm | Metformin (NPC230775) | NP level |
NCT00611000 | Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia | colorectal carcinoma | Folic Acid (NPC147983) | NP level |
NCT00353691 | Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00325572 | Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism | autism | Ascorbate (NPC187770) | NP level |
NCT00243711 | A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop | dry eye syndrome | Glycerin (NPC157340) | NP level |
NCT00080275 | Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT01340768 | Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01117584 | A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02868151 | Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers | oral mucositis | Ascorbate (NPC187770) | NP level |
NCT00446147 | Study of Pyridoxine for Hand-Foot Syndrome | Hand-foot syndrome | Pyridoxine (NPC269919) | NP level |
NCT05501548 | Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer | prostate cancer | Ascorbate (NPC187770) | NP level |
NCT00150722 | High-Density Lipoprotein (HDL) Modulation and Endothelial Function | atherosclerosis | Niacin (NPC167400) | NP level |
NCT03651531 | Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
NCT02360618 | Metformin and Simvastatin Use in Bladder Cancer | urinary bladder cancer | Metformin (NPC230775) | NP level |
NCT00455416 | Dietary Intervention in Follicular Lymphoma | follicular lymphoma | Quercetin (NPC20791) | NP level |
NCT03017833 | Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers | neoplasm | Metformin (NPC230775) | NP level |
NCT00427154 | Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02484209 | DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study) | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01864681 | Combination of Metformin With Gefitinib to Treat NSCLC | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT02365597 | An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer | urogenital neoplasm | Metformin (NPC230775) | NP level |
NCT00263965 | ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01490944 | Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls | anemia (phenotype) | Folic Acid (NPC147983) | NP level |
NCT01482286 | Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT04300790 | Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients | breast cancer | Metformin (NPC230775) | NP level |
NCT00096330 | Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer | colorectal carcinoma | Folic Acid (NPC147983) | NP level |
NCT04630964 | The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density | major depressive disorder | Niacin (NPC167400) | NP level |
NCT01005303 | Micronutrient Supplementation in Patients With Heart Failure | heart failure | Niacin (NPC167400);Retinol (NPC55412);Pyridoxine (NPC269919);Ascorbate (NPC187770);Folic Acid (NPC147983) | NP level |
NCT00520247 | Effect of Enalapril Plus Folic Acid on Blood Pressure and Glycometabolism | hypertension | Folic Acid (NPC147983) | NP level |
NCT02088034 | Intervention to Promote Weight Loss in Latinas At-risk for Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00533611 | Effect of MK0524A on Flushing Caused by Niacin (0524A-056) | Flushing | Niacin (NPC167400) | NP level |
NCT03882177 | StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis | pulmonary tuberculosis | Pyridoxine (NPC269919) | NP level |
NCT04478734 | Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease | Huntington disease | Thiamine (NPC150950) | NP level |
NCT00809536 | Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time | generalized anxiety disorder | Metformin (NPC230775) | NP level |
NCT01005303 | Micronutrient Supplementation in Patients With Heart Failure | heart failure | Thiamine (NPC150950) | NP level |
NCT00038727 | Diabetes Prevention Program Outcomes Study | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02895750 | Efficacity and Safety of Metformin XR in CKD Stage 1 to 3 | chronic kidney disease | Metformin (NPC230775) | NP level |
NCT02506777 | Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. | breast cancer | Metformin (NPC230775) | NP level |
NCT04363216 | Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT00673465 | Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01381354 | Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) | multiple sclerosis | Thiamine (NPC150950) | NP level |
NCT03320694 | Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
NCT01348204 | Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators | cystic fibrosis | Quercetin (NPC20791) | NP level |
NCT00698230 | Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00767000 | Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03418038 | Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or Clonal Cytopenia of Undetermined Significance | Hodgkins lymphoma | Ascorbate (NPC187770) | NP level |
NCT01687218 | Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel | HIV infection | Glycerin (NPC157340) | NP level |
NCT01210911 | Metformin Combined With Chemotherapy for Pancreatic Cancer | pancreatic carcinoma | Metformin (NPC230775) | NP level |
NCT00184574 | Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00707031 | GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00968812 | CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02946996 | Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy | prostate cancer | Metformin (NPC230775) | NP level |
NCT02905591 | A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
NCT04851821 | The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) | COVID-19 | Quercetin (NPC20791) | NP level |
NCT04907253 | Quercetin in Coronary Artery By-pass Surgery | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT00000541 | Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) | Myocardial Ischemia | Folic Acid (NPC147983);Beta Carotene (NPC17810);Pyridoxine (NPC269919) | NP level |
NCT02956044 | Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02682121 | Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo | prediabetes syndrome | Metformin (NPC230775) | NP level |
NCT01106677 | The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00322764 | Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression | bipolar disorder | Uridine (NPC43246) | NP level |
NCT05062486 | A Study to Evaluate the Safety and Efficacy of RQC for AMD | age-related macular degeneration | Quercetin (NPC20791) | NP level |
NCT01211197 | Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01116141 | A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00108615 | Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01502280 | Fluorescence-guided Surgery for Low- and High-grade Gliomas | glioma | Ascorbate (NPC187770) | NP level |
NCT00378833 | Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
NCT04141163 | Metformin in Patients With Fragile X | fragile X syndrome | Metformin (NPC230775) | NP level |
NCT01528046 | Metformin in Children With Relapsed or Refractory Solid Tumors | brain neoplasm | Metformin (NPC230775) | NP level |
NCT01137812 | The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01183065 | Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) | head and neck malignant neoplasia | Folic Acid (NPC147983) | NP level |
NCT00881530 | Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02437656 | Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP). | rectum cancer | Metformin (NPC230775) | NP level |
NCT01953536 | Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) | breast neoplasm | Folic Acid (NPC147983) | NP level |
NCT00295633 | A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00541775 | Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02621060 | Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance | abnormal glucose tolerance | Chlorogenic Acid (NPC302857) | NP level |
NCT01107717 | Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00466622 | Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00210080 | A Study to Diagnose Lung Cancer by Sputum Cytology (01-312) | lung cancer | Uridine (NPC43246) | NP level |
NCT00331851 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00097279 | Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01240759 | Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03334409 | Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery | clear cell renal carcinoma | Ascorbate (NPC187770) | NP level |
NCT00571519 | Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05394142 | A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00618995 | A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
NCT02773927 | Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
NCT01368081 | Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04046094 | Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients | urinary bladder cancer | Ascorbate (NPC187770) | NP level |
NCT04264897 | Antecedent Metabolic Health and Metformin Aging Study | aging;insulin resistance | Metformin (NPC230775) | NP level |
NCT02168270 | Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma | anaplastic astrocytoma;anaplastic oligodendroglioma;gliosarcoma | Ascorbate (NPC187770) | NP level |
NCT00918138 | Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02699099 | Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. | malaria | Retinol (NPC55412) | NP level |
NCT00000461 | Harvard Atherosclerosis Reversibility Project (HARP) | Myocardial Ischemia | Niacin (NPC167400) | NP level |
NCT04926155 | The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer | metastatic prostate cancer | Metformin (NPC230775) | NP level |
NCT04510194 | COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) | COVID-19;severe acute respiratory syndrome | Metformin (NPC230775) | NP level |
NCT01217814 | Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT01900431 | Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis | uveitis | Folic Acid (NPC147983) | NP level |
NCT04780854 | Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN) | peripheral neuropathy | Metformin (NPC230775) | NP level |
NCT03649633 | Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock | septic shock | Ascorbate (NPC187770) | NP level |
NCT00953134 | Periconceptional Iron Supplementation in Rural Bangladesh | anemia (phenotype) | Folic Acid (NPC147983) | NP level |
NCT02823691 | The MetNET-2 Trial | neuroendocrine neoplasm | Metformin (NPC230775) | NP level |
NCT00131664 | Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02541045 | Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis | non-alcoholic fatty liver disease | Pyridoxine (NPC269919) | NP level |
NCT00151411 | Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT02702492 | PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA) | non-Hodgkins lymphoma | Niacin (NPC167400) | NP level |
NCT02244567 | Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01356966 | Exercise Intolerance in Renal Failure | chronic kidney disease | Folic Acid (NPC147983) | NP level |
NCT01071525 | The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT04928495 | Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19 | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT00715624 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01087983 | Lapatinib With Sirolimus or Metformin | cancer | Metformin (NPC230775) | NP level |
NCT00814372 | Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02186847 | Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer | bronchoalveolar adenocarcinoma;large cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT00301587 | A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives | neural tube defect | Folic Acid (NPC147983) | NP level |
NCT00000553 | HDL-Atherosclerosis Treatment Study (HATS) | Myocardial Ischemia | Niacin (NPC167400) | NP level |
NCT00133406 | Long-term Impact and Intervention for Diarrhea in Brazil | diarrheal disease | Retinol (NPC55412) | NP level |
NCT01850680 | Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT04677049 | Study of Niacin in Glioblastoma | glioblastoma multiforme | Niacin (NPC167400) | NP level |
NCT03541486 | A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients | pancreatic neoplasm | Ascorbate (NPC187770) | NP level |
NCT00614055 | Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01881828 | Metformin Therapy for Overweight Adolescents With Type 1 Diabetes | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00500045 | Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions | retinal vein occlusion | Niacin (NPC167400) | NP level |
NCT00154700 | Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer | esophageal cancer | Folic Acid (NPC147983) | NP level |
NCT00901979 | A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00056225 | VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study) | Alzheimer disease | Folic Acid (NPC147983);Pyridoxine (NPC269919) | NP level |
NCT00000599 | Cholesterol-Lowering Atherosclerosis Study (CLAS) | carotid artery disease;cerebral atherosclerosis;Myocardial Ischemia | Niacin (NPC167400) | NP level |
NCT02109614 | Early Aortic Valve Lipoprotein(a) Lowering Trial | aortic stenosis | Niacin (NPC167400) | NP level |
NCT02107976 | Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes | diabetes mellitus | Ascorbate (NPC187770) | NP level |
NCT00266253 | A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05215990 | Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis | tuberculosis | Metformin (NPC230775) | NP level |
NCT04248998 | Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer | triple-negative breast cancer | Metformin (NPC230775) | NP level |
NCT00948402 | PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00087516 | Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00915772 | Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05131828 | CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy | multiple sclerosis | Metformin (NPC230775) | NP level |
NCT01368328 | Effect of the Chromium Nicotinate on Type 2 Diabetes | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
NCT02245204 | Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers | cancer | Chlorogenic Acid (NPC302857) | NP level |
NCT00713830 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01575405 | A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally | HIV infection | Glycerin (NPC157340) | NP level |
NCT00961909 | A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03510715 | An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT02063802 | Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children | obesity | Metformin (NPC230775) | NP level |
NCT00441870 | Study of EC0225 for the Treatment of Refractory or Metastatic Tumors | cancer | Folic Acid (NPC147983) | NP level |
NCT05096663 | Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
NCT01885013 | Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients | breast carcinoma | Metformin (NPC230775) | NP level |
NCT00480207 | Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults | depressive disorder | Folic Acid (NPC147983) | NP level |
NCT04224051 | Metformin for Abdominal Aortic Aneurysm Growth Inhibition | Abdominal Aortic Aneurysm | Metformin (NPC230775) | NP level |
NCT00941382 | Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients | obesity | Metformin (NPC230775) | NP level |
NCT02066688 | Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer | colorectal neoplasm | Folic Acid (NPC147983) | NP level |
NCT03101579 | Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer | leptomeningeal metastasis | Folic Acid (NPC147983) | NP level |
NCT01566799 | Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer | neoplasm | Metformin (NPC230775) | NP level |
NCT00482729 | MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02589145 | Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype | lymphoma | Pyridoxine (NPC269919) | NP level |
NCT01438320 | Q-Trial in Patients With Hepatitis C | chronic hepatitis C virus infection | Quercetin (NPC20791) | NP level |
NCT02498522 | Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT02042664 | Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00961636 | A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT01093794 | Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01002807 | Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00063232 | Treating Nonalcoholic Steatohepatitis (NASH) With Metformin | Hepatitis | Metformin (NPC230775) | NP level |
NCT04530747 | Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea | obstructive sleep apnea | Metformin (NPC230775) | NP level |
NCT00425009 | Therapeutic Effects of Berberine in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02541708 | IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania | Iron deficiency anemia | Folic Acid (NPC147983) | NP level |
NCT00269217 | Lipid Efficacy Study (0524B-022)(COMPLETED) | Combined hyperlipidemia;Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT00839527 | A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03137186 | Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
NCT04898023 | Zinc and Green Tea Extract for Community Respiratory Viral Infections | viral disease | Ascorbate (NPC187770) | NP level |
NCT01070810 | Thiamine as a Metabolic Resuscitator in Septic Shock | septic shock | Thiamine (NPC150950) | NP level |
NCT00554827 | Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma | Cutaneous T-cell lymphoma | Folic Acid (NPC147983) | NP level |
NCT00860288 | Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01076088 | Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03258723 | Diabetes Prevention With Lifestyle Intervention and Metformin Escalation | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01383356 | Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00110851 | Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01215331 | Gestational Diabetes: Insulin or Oral Hypoglycemic Agents? | gestational diabetes | Metformin (NPC230775) | NP level |
NCT00082251 | Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT00965653 | A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00376038 | Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01779375 | RISE Pediatric Medication Study | prediabetes syndrome | Metformin (NPC230775) | NP level |
NCT04715022 | Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study) | hypertension | Ascorbate (NPC187770) | NP level |
NCT02659306 | Metformin Immunotherapy in HIV Infection | HIV infection | Metformin (NPC230775) | NP level |
NCT00954525 | Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
NCT00420511 | Beta-Cell Function and Sitagliptin Trial (BEST) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04143282 | Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment | breast cancer | Metformin (NPC230775) | NP level |
NCT03030300 | Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02093026 | Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT02890992 | An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | colorectal cancer | Folic Acid (NPC147983) | NP level |
NCT00098319 | Oral Cleft Prevention Trial in Brazil | cleft lip;Cleft palate | Folic Acid (NPC147983) | NP level |
NCT05262257 | Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00067951 | A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02786823 | Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Folic Acid (NPC147983) | NP level |
NCT03981861 | Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT03510884 | An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT04899349 | Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | breast cancer | Metformin (NPC230775) | NP level |
NCT01852890 | Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | pancreatic neoplasm | Ascorbate (NPC187770) | NP level |
NCT01720095 | Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis | psychosis | Niacin (NPC167400) | NP level |
NCT01589367 | Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT00441207 | Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors | cancer | Ascorbate (NPC187770) | NP level |
NCT02042495 | Endometrial Cancer Biomarker Changes Following Exposure to Metformin | endometrial cancer | Metformin (NPC230775) | NP level |
NCT05452772 | 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder | nicotine dependence | Niacin (NPC167400) | NP level |
NCT01985685 | The Effect of Thiamine vs. Placebo on VO2 in Critical Illness | respiratory failure | Thiamine (NPC150950) | NP level |
NCT01042379 | I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | angiosarcoma;triple-negative breast cancer | Metformin (NPC230775) | NP level |
NCT01204294 | Comprehensive Add on Study in Japan | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | colorectal carcinoma | Pyridoxine (NPC269919) | NP level |
NCT01710527 | BE Study of Metformin GSK 500mg | diabetic foot | Metformin (NPC230775) | NP level |
NCT00493064 | To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions | retinal vein occlusion | Niacin (NPC167400) | NP level |
NCT01905150 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
NCT02283554 | Platelet Rich Fibrin With 1% Metformin Gel for Treatment of Intrabony Defects | periodontitis | Metformin (NPC230775) | NP level |
NCT02689843 | Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01068717 | Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03224572 | The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients | ascorbic acid deficiency | Ascorbate (NPC187770) | NP level |
NCT03229057 | Comparing the Effects of Oral Contraceptive Pills Versus Metformin | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01071291 | Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT00382096 | Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00734474 | A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00348725 | Acceptability of a Fixed Combination of Fenofibrate and Metformin | metabolic disease | Metformin (NPC230775) | NP level |
NCT02593097 | Metformin for the Prevention of Episodic Migraine (MPEM) | migraine disorder | Metformin (NPC230775) | NP level |
NCT03863405 | Metformin Use in Rheumatoid Arthritis | rheumatoid arthritis | Metformin (NPC230775) | NP level |
NCT02330341 | Effect of Artemisia Dracunculus on Glucose Intolerance;Insulin Sensitivity and Insulin Secretion | Glucose Intolerance | Artemisia Dracunculus | Plant level As single plant |
NCT01562626 | Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors | cancer | Maltose (NPC246558) | NP level |
NCT00111631 | A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03479476 | A Trial of Metformin in Individuals With Fragile X Syndrome | fragile X syndrome;Intellectual disability;neurobehavioral manifestations;sex chromosome disorder of sex development | Metformin (NPC230775) | NP level |
NCT02344355 | A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
NCT04209075 | Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber) | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01717482 | Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT00851903 | Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01054508 | Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT00971243 | Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00804843 | Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) | carotid atherosclerosis | Niacin (NPC167400) | NP level |
NCT04615351 | A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
NCT00763451 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01711359 | A Study in Participants With Moderate to Severe Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT04196868 | Methotrexate and Metformin in Rheumatoid Arthritis Patients | rheumatoid arthritis | Metformin (NPC230775) | NP level |
NCT00881725 | A Study of Pre-operative Metformin in Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
NCT02819869 | The Combination Effect of Statin Plus Metformin on Relapse-free | hepatocellular carcinoma | Metformin (NPC230775) | NP level |
NCT01873443 | Long-Term Efficacy and Safety of CT-P10 in Patients With RA | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00631488 | A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00097500 | Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01321034 | Effect of Niacin in the Lipoprotein (a) Concentration | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT04998032 | A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02793648 | Effectiveness of Ascorbic Acid and Tocopherol for Depression in Elderly. | depressive disorder | Ascorbate (NPC187770) | NP level |
NCT01353391 | Metformin in Women With Type 2 Diabetes in Pregnancy Trial | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00519480 | A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03581773 | Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy | mucositis | Folic Acid (NPC147983) | NP level |
NCT04946383 | Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging | aging | Quercetin (NPC20791) | NP level |
NCT00700817 | The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03841591 | Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin | gestational diabetes | Metformin (NPC230775) | NP level |
NCT03151772 | Bioavailability of Disulfiram and Metformin in Glioblastomas | glioblastoma multiforme | Metformin (NPC230775) | NP level |
NCT01705652 | Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients | prostate cancer | Rutin (NPC176740) | NP level |
NCT00998946 | Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | lymphoma | Folic Acid (NPC147983) | NP level |
NCT02206425 | Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT00614120 | Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02022007 | Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00120146 | Glaser Obesity Study | obesity | Metformin (NPC230775) | NP level |
NCT02949700 | Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Metformin (NPC230775) | NP level |
NCT00397657 | Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis | atherosclerosis | Niacin (NPC167400) | NP level |
NCT01677897 | Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients | metastatic prostate cancer | Metformin (NPC230775) | NP level |
NCT04691960 | A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging | glioblastoma multiforme | Metformin (NPC230775) | NP level |
NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | colorectal carcinoma | Pyridoxine (NPC269919) | NP level |
NCT04750135 | Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis | ulcerative colitis | Metformin (NPC230775) | NP level |
NCT02791906 | Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease | chronic kidney disease | Ascorbate (NPC187770) | NP level |
NCT00258245 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT00841269 | Oral Uridine for Treatment of Bipolar Depression in Adolescents | bipolar disorder | Uridine (NPC43246) | NP level |
NCT00272610 | Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin | Purpura | Retinol (NPC55412) | NP level |
NCT05298670 | Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients | multiple sclerosis | Metformin (NPC230775) | NP level |
NCT02013362 | Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Folic Acid (NPC147983) | NP level |
NCT00976937 | 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02655913 | Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer | non-small cell lung carcinoma | Ascorbate (NPC187770) | NP level |
NCT05236530 | Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir | malaria | Metformin (NPC230775) | NP level |
NCT00899470 | Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01104519 | A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT00349635 | A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients. | obesity | Metformin (NPC230775) | NP level |
NCT00112879 | Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT02472353 | Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT03833466 | Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo) | esophageal squamous cell carcinoma | Metformin (NPC230775) | NP level |
NCT02372656 | Simvastatin and Metformin in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
NCT00630877 | Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT00631033 | DZX Mediated Insulin Suppression in Obese Men | obesity | Metformin (NPC230775) | NP level |
NCT00783744 | Insulin Glargine Combination Therapies in Type II Diabetics | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04416269 | Oral Anti Diabetic Agents in the Hospital | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00286442 | Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01115504 | Thiamine Supplementation in Heart Failure Patients Receiving Full Medical Therapy | heart failure | Thiamine (NPC150950) | NP level |
NCT00000482 | Coronary Drug Project | Myocardial Ischemia;myocardial infarction | Niacin (NPC167400) | NP level |
NCT00627445 | Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02461667 | Alendronate Compared to Metformin in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
NCT00676338 | Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00361868 | Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI | Disorder of lipid metabolism | Metformin (NPC230775) | NP level |
NCT04414540 | Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients | head and neck squamous cell carcinoma | Metformin (NPC230775) | NP level |
NCT00086502 | Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01169779 | Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00114400 | BVAIT: B-Vitamin Atherosclerosis Intervention Trial | atherosclerosis | Pyridoxine (NPC269919);Folic Acid (NPC147983) | NP level |
NCT03481790 | Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy | Iron deficiency anemia | Folic Acid (NPC147983) | NP level |
NCT01010581 | SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT03333278 | The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial | Sepsis;septic shock | Ascorbate (NPC187770);Thiamine (NPC150950) | NP level |
NCT03204071 | Locally Delivered Metformin and Aloe Vera for Treatment of Intrabody Defects in Chronic Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
NCT04900792 | A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
NCT01318109 | Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01670955 | The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients | anemia (phenotype) | Folic Acid (NPC147983) | NP level |
NCT03722290 | Metformin in Children and Adults With Fragile X Syndrome | fragile X syndrome | Metformin (NPC230775) | NP level |
NCT01766778 | Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02580331 | 1% Metformin Gel in the Treatment of Class II Furcation Defects | periodontitis | Metformin (NPC230775) | NP level |
NCT04121468 | A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children With Multiple Sclerosis | multiple sclerosis | Metformin (NPC230775) | NP level |
NCT00406874 | Effect of Omega 3 Fats on Sperm Quality and Sexual Function | infertility | Folic Acid (NPC147983) | NP level |
NCT00971659 | Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00006021 | Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT02457286 | Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study | non-alcoholic fatty liver disease | Metformin (NPC230775) | NP level |
NCT01650506 | Study of Erlotinib and Metformin in Triple Negative Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT00002650 | High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed | colorectal carcinoma | Folic Acid (NPC147983) | NP level |
NCT05183204 | Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma | glioblastoma multiforme | Metformin (NPC230775) | NP level |
NCT00755287 | A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00855257 | Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome | acute coronary syndrome | Niacin (NPC167400) | NP level |
NCT01234649 | Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) | abnormal glucose tolerance;metabolic syndrome | Metformin (NPC230775) | NP level |
NCT01620593 | Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
NCT02293902 | A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT01064687 | A Study in Participants With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04581447 | Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04055012 | Effects of Metformin on Low Back Pain | Low back pain | Metformin (NPC230775) | NP level |
NCT01434186 | A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02437812 | Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma | ovarian carcinoma | Metformin (NPC230775) | NP level |
NCT01080352 | Vitamin C as an Anti-cancer Drug | prostate adenocarcinoma | Ascorbate (NPC187770) | NP level |
NCT00251953 | GALLANT 8 Tesaglitazar Add-on to Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04335084 | A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT00712673 | GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00159536 | Metformin in Pregnant PCOS Women | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01997775 | Metformin in Stage IV Lung Adenocarcinoma | non-small cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT00143702 | D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE) | lactic acidosis | Thiamine (NPC150950) | NP level |
NCT03076281 | Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery | oral squamous cell carcinoma | Metformin (NPC230775) | NP level |
NCT04972396 | ALT-801 DDI Study in Healthy Volunteers | non-alcoholic steatohepatitis | Metformin (NPC230775) | NP level |
NCT00350779 | Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03866174 | A Study of Psilocybin for Major Depressive Disorder (MDD) | major depressive disorder | Niacin (NPC167400) | NP level |
NCT01335386 | Investigation of KLYX in Patients With Constipation | Constipation | Glycerin (NPC157340) | NP level |
NCT04952051 | Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension | hypertension | Folic Acid (NPC147983) | NP level |
NCT00957359 | Psilocybin Cancer Anxiety Study | cancer | Niacin (NPC167400) | NP level |
NCT01550510 | Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | colorectal adenocarcinoma | Ascorbate (NPC187770) | NP level |
NCT01175473 | Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01087866 | Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus | gestational diabetes | Metformin (NPC230775) | NP level |
NCT03887169 | Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. | pulmonary alveolar proteinosis | Ascorbate (NPC187770);Pyridoxine (NPC269919);Folic Acid (NPC147983) | NP level |
NCT00289900 | Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) | Combined hyperlipidemia | Niacin (NPC167400) | NP level |
NCT01057589 | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer | upper aerodigestive tract neoplasm | Folic Acid (NPC147983) | NP level |
NCT00203476 | A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
NCT00328172 | Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04428086 | A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. | neoplasm | Metformin (NPC230775) | NP level |
NCT02967276 | Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma | multiple myeloma | Metformin (NPC230775) | NP level |
NCT01891747 | A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma | malignant glioma | Ascorbate (NPC187770) | NP level |
NCT00127218 | High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly | atherosclerosis | Niacin (NPC167400) | NP level |
NCT01779362 | RISE Adult Medication Study | prediabetes syndrome | Metformin (NPC230775) | NP level |
NCT04301336 | Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia | sickle cell anemia | Folic Acid (NPC147983) | NP level |
NCT00714233 | Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT03047837 | A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients. | malignant colon neoplasm | Metformin (NPC230775) | NP level |
NCT00303537 | Metformin in Non-Alcoholic Fatty Liver Disease | Hepatic steatosis | Metformin (NPC230775) | NP level |
NCT01329016 | Glyburide and Metformin for Gestational Diabetes Mellitus (GDM) | gestational diabetes | Metformin (NPC230775) | NP level |
NCT02506790 | Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT00174642 | Opposing Step-by-step Insulin Reinforcement to Intensified Strategy | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00485758 | Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069) | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
NCT00924573 | Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01465113 | Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus | Barrett's esophagus | Metformin (NPC230775) | NP level |
NCT00841256 | Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children | allergic conjunctivitis | Glycerin (NPC157340) | NP level |
NCT00313313 | A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00432276 | Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00536237 | MK0524A Phase IIb Study (0524A-011)(COMPLETED) | Flushing | Niacin (NPC167400) | NP level |
NCT02297399 | Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients | diabetes mellitus | Ascorbate (NPC187770) | NP level |
NCT05276895 | Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis | osteoarthritis | Quercetin (NPC20791) | NP level |
NCT03872011 | Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock | septic shock | Thiamine (NPC150950);Ascorbate (NPC187770) | NP level |
NCT00120289 | Niacin Plus Statin to Prevent Vascular Events | stroke;atherosclerosis;myocardial infarction | Niacin (NPC167400) | NP level |
NCT02587741 | Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens | diabetic retinopathy | Metformin (NPC230775) | NP level |
NCT01075282 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03108963 | L-carnitine and Metformin in Obese PCOS Women. | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00170404 | TB Nutrition, Immunology and Epidemiology | tuberculosis | Niacin (NPC167400);Retinol (NPC55412);Folic Acid (NPC147983) | NP level |
NCT02467504 | Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT01302145 | Drug to Drug Interaction Study With ASP1941 and Metformin | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00820573 | Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04220021 | Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD | frontotemporal dementia | Metformin (NPC230775) | NP level |
NCT03624270 | Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia | acute promyelocytic leukemia | Ascorbate (NPC187770) | NP level |
NCT00508989 | Niacin to Improve Blood Flow in People With Sickle Cell Disease | sickle cell anemia | Niacin (NPC167400) | NP level |
NCT00216099 | Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer | prostate cancer | Folic Acid (NPC147983) | NP level |
NCT01569919 | A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma | mesothelioma | Folic Acid (NPC147983) | NP level |
NCT00375388 | The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00626392 | Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT04404387 | Lessening Organ Dysfunction With VITamin C in Septic ARDS | acute respiratory distress syndrome | Ascorbate (NPC187770) | NP level |
NCT00875394 | Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00683735 | Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01407432 | Impact of Folates in the Care of the Male Infertility | male infertility | Folic Acid (NPC147983) | NP level |
NCT01034111 | A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02190838 | Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma | melanoma | Metformin (NPC230775) | NP level |
NCT01221402 | Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis | atherosclerosis | Niacin (NPC167400) | NP level |
NCT01483560 | REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL) | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03008551 | Empagliflozin vs Metformin in PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00762957 | Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04783792 | The Effect of Phenolic Compounds in Osteoarthritis; a Nutritional Intervention | osteoarthritis | Ascorbate (NPC187770) | NP level |
NCT02728349 | Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma | glioblastoma multiforme | Chlorogenic Acid (NPC302857) | NP level |
NCT00580606 | A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial | peanut allergic reaction | Glycerin (NPC157340) | NP level |
NCT03861767 | REMAP Trial for Optimizing Surgical Outcomes at UPMC | aging | Metformin (NPC230775) | NP level |
NCT01715597 | Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma | uterine fibroid | Ascorbate (NPC187770) | NP level |
NCT02274090 | 1% Metformin in Moderate and Severe Periodontitis | periodontitis | Metformin (NPC230775) | NP level |
NCT01192139 | Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN) | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02780024 | Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM | glioblastoma multiforme | Metformin (NPC230775) | NP level |
NCT02186158 | Interest of Ascorbic Acid in the Management of Pneumonia in Elderly People Hospitalized. | pneumonia | Ascorbate (NPC187770) | NP level |
NCT02656017 | Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
NCT01106625 | The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01720147 | Quercetin in Children With Fanconi Anemia; a Pilot Study | Fanconi anemia | Quercetin (NPC20791) | NP level |
NCT00449605 | A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00316082 | Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02833350 | Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT01167738 | Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Metformin (NPC230775) | NP level |
NCT00792935 | A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01981525 | A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome | Li-Fraumeni syndrome | Metformin (NPC230775) | NP level |
NCT01638676 | A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients | melanoma | Metformin (NPC230775) | NP level |
NCT01023581 | Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01324180 | Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Metformin (NPC230775) | NP level |
NCT01046500 | Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
NCT04826692 | TEsting METformin Against Cognitive Decline in HD | Huntington disease | Metformin (NPC230775) | NP level |
NCT01215032 | Metformin in Castration-Resistant Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
NCT01839344 | Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes. | type 2 diabetes mellitus | Quercetin (NPC20791) | NP level |
NCT00379769 | RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00770445 | Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus. | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00000161 | Randomized Trials of Vitamin Supplements and Eye Disease | cataract;macular degeneration | Ascorbate (NPC187770);Beta Carotene (NPC17810) | NP level |
NCT03437902 | Impact of Rutin and Vitamin C Combination on Oxidative Stress, Insulin Sensitivity and Lipid Profile in Type 2 Diabetic Patients | type 2 diabetes mellitus | Ascorbate (NPC187770) | NP level |
NCT03259919 | Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT04279535 | Topical Vitamin C for Treatment of Basal Cell Cancer | basal cell carcinoma | Ascorbate (NPC187770) | NP level |
NCT00298272 | Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT01814748 | A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028) | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01733836 | Prostate Cancer Active Surveillance Metformin Trial | prostate cancer | Metformin (NPC230775) | NP level |
NCT03086005 | Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome. | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01037660 | Effects of Lipemia and Metformin on Endothelial Function | cardiovascular disease | Metformin (NPC230775) | NP level |
NCT00661544 | Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT00128557 | Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh | vitamin A deficiency | Retinol (NPC55412) | NP level |
NCT01095666 | A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01575418 | An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations | HIV infection | Glycerin (NPC157340) | NP level |
NCT00691197 | Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear | Abnormality of refraction | Glycerin (NPC157340) | NP level |
NCT00544518 | Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00722371 | MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00362323 | Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO | metabolic disease | Metformin (NPC230775) | NP level |
NCT00920413 | Oral Vitamin C for Correction of Anemia in Patients Receiving Peritoneal Dialysis | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
NCT04050098 | Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg. | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02018965 | Niacin on Immune Activation : a Proof-of-concept Study | HIV infection | Niacin (NPC167400) | NP level |
NCT05283954 | Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT01477060 | Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT02961816 | Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma | lymphoma | Pyridoxine (NPC269919) | NP level |
NCT01381900 | A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03994744 | Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC | small cell lung carcinoma | Metformin (NPC230775) | NP level |
NCT04801511 | Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer | rectum cancer | Ascorbate (NPC187770) | NP level |
NCT00046462 | Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01071850 | A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00470522 | Study of Methotrexate in Lupus Erythematosus | systemic lupus erythematosus | Folic Acid (NPC147983) | NP level |
NCT02064374 | Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects | HIV infection | Metformin (NPC230775) | NP level |
NCT04852510 | Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01266486 | Effect of Metformin on Breast Cancer Metabolism | breast cancer | Metformin (NPC230775) | NP level |
NCT03618654 | Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma | oral squamous cell carcinoma;oropharynx squamous cell carcinoma | Metformin (NPC230775) | NP level |
NCT00769132 | A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19;influenza;pneumonia | Ascorbate (NPC187770) | NP level |
NCT02936830 | Effectiveness of Nanohydroxyapetite Paste on Reducing Dentin Hypersensitivity | allergic disease | Glycerin (NPC157340) | NP level |
NCT05132439 | MetfOrmin BenefIts Lower Extremities With Intermittent Claudication | intermittent vascular claudication | Metformin (NPC230775) | NP level |
NCT04446104 | A Preventive Treatment for Migrant Workers at High-risk of COVID-19 | COVID-19 | Ascorbate (NPC187770) | NP level |
NCT02947750 | Neurovascular Transduction During Exercise in Chronic Kidney Disease | chronic kidney disease | Folic Acid (NPC147983) | NP level |
NCT00961480 | A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00754403 | Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01426438 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | HIV-1 infection | Niacin (NPC167400) | NP level |
NCT02730949 | D-chiro-Inositol in Overweight Type 1 Diabetes Patients | type 1 diabetes mellitus | Folic Acid (NPC147983) | NP level |
NCT02755844 | Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients | endometrial cancer | Metformin (NPC230775) | NP level |
NCT03674385 | Efficacy of Vit E in PCOS Resistant to Clomiphene Citrate | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT04939935 | Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
NCT04921189 | Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors | cardiac arrest | Ascorbate (NPC187770);Thiamine (NPC150950) | NP level |
NCT04867252 | Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00684528 | A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00481663 | A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02424201 | Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja. | postpartum hemorrhage | Ascorbate (NPC187770) | NP level |
NCT02734147 | High Dose Intravenous Ascorbic Acid in Severe Sepsis | Sepsis | Ascorbate (NPC187770) | NP level |
NCT01106690 | The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Metformin (NPC230775) | NP level |
NCT03522922 | Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring | acne | Ascorbate (NPC187770) | NP level |
NCT02644954 | Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis | psoriasis | Metformin (NPC230775) | NP level |
NCT01703104 | The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia | sickle cell anemia | Folic Acid (NPC147983) | NP level |
NCT02249910 | Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02308228 | Metformin to Augment Strength Training Effective Response in Seniors (MASTERS) | aging | Metformin (NPC230775) | NP level |
NCT00525330 | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04733534 | An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer | childhood cancer | Quercetin (NPC20791) | NP level |
NCT03681197 | Metformin Use and Clinical Pregnancy Rate in Women With Unexplained Infertility | infertility | Metformin (NPC230775) | NP level |
NCT05422885 | Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease | aging | Quercetin (NPC20791) | NP level |
NCT03175341 | Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | breast cancer | Ascorbate (NPC187770) | NP level |
NCT03223519 | COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS) | muscular disease | Ascorbate (NPC187770) | NP level |
NCT01685281 | Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder | attention deficit hyperactivity disorder | Pyridoxine (NPC269919) | NP level |
NCT03764605 | Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease | Autosomal dominant polycystic kidney disease | Metformin (NPC230775) | NP level |
NCT03908333 | High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Ascorbate (NPC187770) | NP level |
NCT00243412 | A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT03356483 | Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study. | obsessive-compulsive disorder | Niacin (NPC167400) | NP level |
NCT01677923 | Obesity in Children and Adolescents: Associated Risks and Early Intervention | obesity | Metformin (NPC230775) | NP level |
NCT01165021 | A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
NCT01089205 | Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02110810 | Indomethacin Decreases Post-ERCP Pancreatitis | acute pancreatitis | Glycerin (NPC157340) | NP level |
NCT03509662 | Vitamin C in Post-cardiac Arrest | cardiac arrest | Ascorbate (NPC187770);Thiamine (NPC150950) | NP level |
NCT01976676 | Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion | habitual abortion | Folic Acid (NPC147983) | NP level |
NCT02379091 | Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT03451266 | Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia | preeclampsia | Ascorbate (NPC187770) | NP level |
NCT01068743 | Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00300352 | Effect of Folic Acid Treatment in Coronary Artery Disease | coronary artery disease | Folic Acid (NPC147983) | NP level |
NCT00299104 | A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00484510 | High Dose Ascorbic Acid Treatment of CMT1A | Charcot-Marie-Tooth disease type 1A | Ascorbate (NPC187770) | NP level |
NCT00617240 | Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth | body weight gain | Metformin (NPC230775) | NP level |
NCT03053544 | Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer | rectum cancer | Metformin (NPC230775) | NP level |
NCT00807807 | Evaluating the Effects of Folic Acid Supplementation in Older Adults: The Folic Acid Supplementation Trial (The FAST Study) | heart disease | Folic Acid (NPC147983) | NP level |
NCT01302002 | The Use of Metformin in Early Breast Cancer Patients Pre-Surgery | breast cancer | Metformin (NPC230775) | NP level |
NCT00728910 | Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT03713801 | Impact of Metformin on Immunity | aging | Metformin (NPC230775) | NP level |
NCT01980823 | Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer | breast cancer | Metformin (NPC230775) | NP level |
NCT02519543 | Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder | bipolar disorder | Metformin (NPC230775) | NP level |
NCT00806819 | Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
NCT00348712 | Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01057615 | Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma | asthma | Ascorbate (NPC187770) | NP level |
NCT04088448 | The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients | major depressive disorder | Metformin (NPC230775) | NP level |
NCT00533312 | MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED) | Hypercholesterolemia | Niacin (NPC167400) | NP level |
NCT02045290 | Insulin Clamp Ancillary Study for Assessment of Insulin Resistance | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00617058 | Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine | body weight gain | Metformin (NPC230775) | NP level |
NCT03651895 | Metformin to Reduce Airway Glucose in COPD Patients | chronic obstructive pulmonary disease | Metformin (NPC230775) | NP level |
NCT03192293 | Metformin and Simvastatin in Addition to Fulvestrant | breast cancer | Metformin (NPC230775) | NP level |
NCT04536805 | Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin | prostate cancer | Metformin (NPC230775) | NP level |
NCT03188445 | Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy. | Iron deficiency anemia | Ascorbate (NPC187770) | NP level |
NCT05349474 | Metformin Treatment in Progressive Multiple Sclerosis | primary progressive multiple sclerosis;secondary progressive multiple sclerosis | Metformin (NPC230775) | NP level |
NCT00269204 | Lipid Efficacy/Tolerability Study (0524A-020) | Combined hyperlipidemia | Niacin (NPC167400) | NP level |
NCT05426044 | Metformin as a Neuroprotective Therapy for Glaucoma - A Randomized Controlled Trial | glaucoma | Metformin (NPC230775) | NP level |
NCT01725126 | To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes | obesity | Metformin (NPC230775) | NP level |
NCT02810132 | Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure | systolic heart failure | Metformin (NPC230775) | NP level |
NCT00396357 | Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02945813 | SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy | prostate cancer | Metformin (NPC230775) | NP level |
NCT01364805 | New Treatment Option for Pancreatic Cancer | pancreatic carcinoma | Ascorbate (NPC187770) | NP level |
NCT03028467 | Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT04113889 | Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT02504671 | Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT00830076 | A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00085345 | Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT00136188 | Nitric Oxide (NO) Activity and Diabetic Nephropathy | diabetic nephropathy | Folic Acid (NPC147983) | NP level |
NCT03905941 | Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00000541 | Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) | Myocardial Ischemia | Ascorbate (NPC187770) | NP level |
NCT00402883 | Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer | lung cancer | Folic Acid (NPC147983) | NP level |
NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | mouth neoplasm | Quercetin (NPC20791) | NP level |
NCT00299130 | A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT04900415 | Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction | COVID-19 | Retinol (NPC55412) | NP level |
NCT01797523 | A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma | endometrial cancer | Metformin (NPC230775) | NP level |
NCT01808690 | EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes | type 1 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00261352 | GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04553666 | Reducing Frailty for Older Cancer Survivors Using Supplements | inflammation | Ascorbate (NPC187770) | NP level |
NCT02719756 | Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2 | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04945148 | Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide | glioblastoma multiforme | Metformin (NPC230775) | NP level |
NCT00469209 | Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT02640534 | Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone | prostate carcinoma | Metformin (NPC230775) | NP level |
NCT00401973 | Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine | schizoaffective disorder;schizophrenia | Metformin (NPC230775) | NP level |
NCT03848533 | Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes | prediabetes syndrome | Metformin (NPC230775) | NP level |
NCT01107730 | Vitamin C for Prophylaxis of Post-operative Atrial Fibrillation in On-pump Cardiac Surgery Procedures | atrial fibrillation | Ascorbate (NPC187770) | NP level |
NCT00699036 | Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) | non-alcoholic steatohepatitis | Metformin (NPC230775) | NP level |
NCT00376584 | Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) | Disorder of lipid metabolism;hyperlipidemia | Niacin (NPC167400) | NP level |
NCT02778776 | Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome | metabolic syndrome | Metformin (NPC230775) | NP level |
NCT05289908 | Intrathecal Pemetrexed for Leptomeningeal Metastasis | leptomeningeal metastasis | Folic Acid (NPC147983) | NP level |
NCT00868790 | A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02393378 | Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT01627067 | Exemestane-RAD001-Metformin | breast cancer | Metformin (NPC230775) | NP level |
NCT02369822 | Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy | epilepsy | Ascorbate (NPC187770) | NP level |
NCT00606502 | Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
NCT00099866 | Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00543361 | Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00763815 | GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01725490 | The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study | Familial adenomatous polyposis | Metformin (NPC230775) | NP level |
NCT01119534 | Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin | Cough | Eucalyptol (NPC287331) | NP level |
NCT04973891 | CANA/Met in Non-diabetic Women With PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT01245166 | A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00086515 | Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00452829 | Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study) | neural tube defect | Folic Acid (NPC147983) | NP level |
NCT01126580 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01874080 | Bioequivalence Study | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02460354 | Metformin and Congenital Nephrogenic Diabetes Insipidus | diabetes insipidus | Metformin (NPC230775) | NP level |
NCT00227682 | Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma | multiple myeloma | Ascorbate (NPC187770) | NP level |
NCT00362440 | Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome | HIV-Associated Lipodystrophy Syndrome | Metformin (NPC230775) | NP level |
NCT01217892 | Evaluation of Dapagliflozin Taken Twice-daily | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01292993 | A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04344184 | SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI) | acute lung injury;COVID-19 | Ascorbate (NPC187770) | NP level |
NCT03090048 | Vitamin A and Azithromycin for Acne Vulgaris | acne | Retinol (NPC55412) | NP level |
NCT00633581 | Efficacy of Vitamin C Injection on Fatigue in Workers After Work | Fatigue | Ascorbate (NPC187770) | NP level |
NCT01752491 | A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme | glioblastoma multiforme | Ascorbate (NPC187770) | NP level |
NCT01912820 | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | prostate adenocarcinoma | Quercetin (NPC20791) | NP level |
NCT02531308 | Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Metformin (NPC230775) | NP level |
NCT01459809 | Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01334125 | Adjunctive Metformin Therapy in Double Diabetes | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03509350 | Vitamin C, Thiamine, and Steroids in Sepsis | Sepsis | Ascorbate (NPC187770);Thiamine (NPC150950) | NP level |
NCT02795299 | Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis | rheumatoid arthritis | Folic Acid (NPC147983) | NP level |
NCT03148236 | Vitamin C in Atrial Fibrillation Ablation | atrial fibrillation | Ascorbate (NPC187770) | NP level |
NCT02878265 | The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian Children | malaria | Retinol (NPC55412) | NP level |
NCT04482686 | Trial of Combination Therapy to Treat COVID-19 Infection | COVID-19;severe acute respiratory syndrome | Ascorbate (NPC187770) | NP level |
NCT00268476 | Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | prostate cancer | Metformin (NPC230775) | NP level |
NCT02026869 | Vaginal Administration of Metformin in PCOS Patients. | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT04703361 | Effects of Ketones and Niacin in Heart Failure Patients | systolic heart failure | Niacin (NPC167400) | NP level |
NCT02969681 | Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer | colorectal neoplasm | Ascorbate (NPC187770) | NP level |
NCT04559308 | The Effect of Metformin on Breast Cancer Patients | breast cancer | Metformin (NPC230775) | NP level |
NCT00842400 | A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects. | obesity | Metformin (NPC230775) | NP level |
NCT00211562 | Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids | schizophrenia | Ascorbate (NPC187770) | NP level |
NCT02563327 | Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis | tuberculosis | Pyridoxine (NPC269919) | NP level |
NCT01095653 | A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02931253 | Metformin as an Upstream Therapy in Atrial Fibrillation | atrial fibrillation | Metformin (NPC230775) | NP level |
NCT02773147 | Effect of Vitamin B on Plasma Neurofilament Light Protein (NFL) in HIV-infected Individuals With Increased Plasma Homocysteine | HIV infection | Folic Acid (NPC147983);Pyridoxine (NPC269919) | NP level |
NCT03200015 | Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma | diffuse large B-cell lymphoma | Metformin (NPC230775) | NP level |
NCT01436266 | Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion | hemorrhage | Folic Acid (NPC147983) | NP level |
NCT00959101 | Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT04832009 | Reversing Glucose and Lipid-mediated Vascular Dysfunction | hypertension | Ascorbate (NPC187770) | NP level |
NCT00664287 | Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082) | Disorder of lipid metabolism | Niacin (NPC167400) | NP level |
NCT01949116 | Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications | HIV infection | Folic Acid (NPC147983) | NP level |
NCT00275418 | Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease | Crohn's disease | Beta Carotene (NPC17810) | NP level |
NCT02516670 | Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer | metastatic prostate cancer | Ascorbate (NPC187770) | NP level |
NCT00399711 | Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01622257 | Cavitation Ultrasound in Treatment of Patients With PCOS | polycystic ovary syndrome | Metformin (NPC230775) | NP level |
NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Folic Acid (NPC147983) | NP level |
NCT03901144 | A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier | atopic eczema | Glycerin (NPC157340) | NP level |
NCT00861523 | Does Thiamine Help Vomiting and Nausea in Pregnancy? | hyperemesis gravidarum | Thiamine (NPC150950) | NP level |
NCT00652431 | Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) | Hypercholesterolemia;hyperlipidemia | Niacin (NPC167400) | NP level |
NCT02225886 | Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients | anemia (phenotype) | Ascorbate (NPC187770) | NP level |
NCT01462266 | Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT02294006 | Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs | pancreatic neuroendocrine tumor | Metformin (NPC230775) | NP level |
NCT02351622 | Caffeic Acid Tablets as a Second-line Therapy for ITP | autoimmune thrombocytopenic purpura | Caffeic Acid (NPC294902) | NP level |
NCT00971295 | Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers | neuropathic pain | Metformin (NPC230775) | NP level |
NCT01464437 | AMG 151 Amgen Protocol Number 20100761 | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00327015 | A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01089192 | Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions. | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT03184493 | Celebrex and Metformin for Postoperative Hepatocellular Carcinoma | liver cancer | Metformin (NPC230775) | NP level |
NCT01936831 | High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) | tuberculosis | Pyridoxine (NPC269919) | NP level |
NCT00152893 | To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities | HIV infection | Niacin (NPC167400) | NP level |
NCT04604678 | Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 | COVID-19 | Metformin (NPC230775) | NP level |
NCT01405118 | Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers | rheumatoid arthritis | Metformin (NPC230775) | NP level |
NCT01578551 | Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. | lung adenocarcinoma | Metformin (NPC230775) | NP level |
NCT03685773 | The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients | type 2 diabetes mellitus | Niacin (NPC167400) | NP level |
NCT03379909 | Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer | urinary bladder cancer | Metformin (NPC230775) | NP level |
NCT01877564 | A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women | adenocarcinoma | Metformin (NPC230775) | NP level |
NCT00349128 | Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes | metabolic disease | Metformin (NPC230775) | NP level |
NCT01305551 | BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00220532 | Folate and Protection Against Cervical Cancer | cervical cancer | Folic Acid (NPC147983) | NP level |
NCT04742751 | An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer | prediabetes syndrome | Metformin (NPC230775) | NP level |
NCT00909506 | Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients | breast cancer | Metformin (NPC230775) | NP level |
NCT01243385 | Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | prostate cancer | Metformin (NPC230775) | NP level |
NCT00885352 | Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT00661362 | Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT05432284 | Behavioral Pharmacology of THC and Beta-Myrcene | cannabis dependence | Myrcene (NPC138113) | NP level |
NCT00803530 | Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes | myelodysplastic syndrome | Ascorbate (NPC187770) | NP level |
NCT01028391 | 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064) | type 2 diabetes mellitus | Metformin (NPC230775) | NP level |
NCT01295450 | Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex | Anorexia | Ascorbate (NPC187770) | NP level |
NCT00626444 | Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) | non-Hodgkins lymphoma | Ascorbate (NPC187770) | NP level |
NCT03800667 | Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries | urinary tract infection | Ascorbate (NPC187770) | NP level |
NCT00953212 | Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery | atrial fibrillation;atrial flutter | Ascorbate (NPC187770) | NP level |
NCT01440127 | Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers | malignant colon neoplasm | Metformin (NPC230775) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
HIF1A,DRD1
NCT03617458,NCT00520247,NCT04952051,NCT00000620,NCT04832009,NCT04715022,NCT01352026 |
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
MET,EGFR,KDR,TYR,MAPK1
NCT01638676,NCT03311308,NCT02143050,NCT02190838 |
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
SRC,TP53
NCT02042495,NCT01911247,NCT02755844,NCT04792749,NCT01797523,NCT01205672,NCT02990728 |
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT02018965,NCT02773147,NCT01949116,NCT00152893,NCT01575405,NCT02064374,NCT01687218,NCT01575418,NCT02659306
|
Diabetes mellitus arising in pregnancyDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA63.2 |
NCT01329016,NCT03841591,NCT03651531,NCT01087866,NCT01215331,NCT03320694,NCT02275845,NCT04615351,NCT00414245
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT01167738,NCT01555489,NCT03889795,NCT03797443,NCT01905150,NCT01488552,NCT00954525,NCT01364805,NCT01210911
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
MMP1,AKR1B1,MMP12,DPP4,NOX4,MMP2,TSHR,MMP9,FLT3
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
CA12,TK1,MMP9,CA9,XDH,MMP1,CDK1,MMP12,AURKB
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
MKNK1,EGFR,IGF1R,KDR,CSNK2A1,MKNK2,MET
NCT03184493 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
SRC,NR3C1,ESR1,NFKB1
NCT04121468,NCT05131828,NCT01381354,NCT05298670 |
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
SLC6A4,IGF1R,ALOX5,ADRA2B,AKR1B1,ACHE,SLC6A2
NCT00631111 |
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TP53,MMP1,SRC,MAPK1,TK1,EGFR,MMP2,IGF1R
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
SLC6A2,XDH,CA2
NCT01005303,NCT02810132,NCT01115504,NCT05093959,NCT04703361 |
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
SRC,ACHE,DRD1,GSK3B,MAPT,SLC6A4,SLC6A3,SNCA
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
ACHE,CYP1A1,ADRA2B,MMP9,YES1,FFAR1
NCT00054938,NCT00470522 |
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NOX4,SLCO1B1,SLC6A3,ALOX15
NCT01796028,NCT01912820,NCT01080352,NCT01996696 |
Periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C |
NCT02283554,NCT02461667,NCT03204058,NCT02048761,NCT02372656,NCT02580331,NCT02274090,NCT03204071
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
DPP4,NOX4,AOX1,MMP2,SULT1A1,CYP1B1,ADRA2B,ESR1
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
CA4,AKR1B1,MET,SLC6A2,ACHE,CA2
NCT05426044 |
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
NR3C1,AHR,ALOX5,NR3C1,NFKB1
NCT00533195,NCT03901144 |
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MMP12,MET,EGFR,CA9,KDR,MMP2,MMP9
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
AHR,ALOX5,DPP4,FLT3,NFKB1
MMP12 NCT02644954 |
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
KDR,EGFR,AHR,AXL,TP53
NCT00329498,NCT00803530 |
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
KDR,TP53,EGFR,MET
NCT01183065,NCT02402348,NCT02325401 |
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
ESR2
NCT02734147,NCT01590303,NCT03680274,NCT03509350,NCT04999137,NCT03333278 |
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
SLC6A3,SLC6A2,SLC6A4
NCT02189772,NCT01243242,NCT00995085,NCT01685281 |
NADisease Category: NADisease ICD-11 Code: NA |
MET,NOX4
NCT00062556,NCT04553666,NCT00781196,NCT00071266,NCT05132439 |
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000541,NCT00000482,NCT00000512,NCT00000461,NCT00000599,NCT00000555,NCT00000553
|
HyperlipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
NCT01583647,NCT00376584,NCT00536510,NCT00203476,NCT00378833,NCT00384293,NCT00652431
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
MMP9
NCT00699036,NCT04972396,NCT02541045,NCT02457286,NCT01084486,NCT02696941 |
Septic shockDisease Category: X.Extension CodesDisease ICD-11 Code: XS26 |
NCT03592693,NCT01070810,NCT03649633,NCT04999137,NCT03333278,NCT03872011,NCT03828929
|
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT02109315,NCT02045290,NCT02730949,NCT01808690,NCT01483560,NCT01881828,NCT04177303
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT00114400,NCT00127218,NCT00120289,NCT00397657,NCT01221402,NCT00000620,NCT00150722
|
AnemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A00-3A9Z |
NCT02631668,NCT01490944,NCT02780505,NCT02225886,NCT01670955,NCT00920413,NCT00953134
|
Intermediate hyperglycaemia, unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.Z |
NCT01804049,NCT01779375,NCT01779362,NCT01336322,NCT02682121,NCT03848533,NCT04742751
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT03072485,NCT04264897,NCT04946383,NCT03713801,NCT03861767,NCT02308228,NCT05422885
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
ACHE,HCAR2,NFKB1,CYP19A1,MET,AXL,DPP4
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
ACHE,SNCA,LMNA,CA4,CA2,SRC,DPP4
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
KDR,MET,SRC,TK1,HCAR2
NCT01037660 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
FFAR1,AURKB,AKR1B1,DPP4,NR3C1,KDR
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
AURKB,DPP4,FLT3,TP53,SRC,CDK1
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
MMP9,KDR,SLC6A2,MET,EGFR,TP53
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
SLC6A4,NR3C1,SLC6A2,SLC6A3,ADRA2B,ACHE
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
ESR1
NCT01407432,NCT00406874,NCT02848950,NCT03135301,NCT03681197 |
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
DRD1,SLC6A4,AKR1B1
NCT04865835,NCT00211562,NCT00401973 |
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
SRC,TP53
NCT00220532,NCT00284427,NCT00703196,NCT04275713 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
MMP9
MMP12,HCAR2,MMP1,MMP9 NCT00275418 |
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT03410030,NCT01578551,NCT03908333,NCT03697239,NCT02186847,NCT01877564
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
NCT01580683,NCT01107730,NCT00953212,NCT02931253,NCT03148236 |
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOX4,APP,ABCG2,SULT1A1,FFAR1,IGF1R
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
ESR1,DPP4,NFKB1
NCT03039075,NCT02484209,NCT00762957,NCT01890122,NCT02297399,NCT00046462,NCT05440591,NCT00820573,NCT00432276,NCT02042664,NCT05262257,NCT01915550,NCT03179254,NCT00683735,NCT02249910,NCT01766778,NCT04050098,NCT02844803,NCT02088034,NCT03258723,NCT01874080,NCT01613755,NCT00727857,NCT01192152,NCT00038727,NCT04209075,NCT01464437,NCT03824002,NCT00286442,NCT00313313,NCT01370707,NCT00316082,NCT00772174,NCT03030300,NCT02107976,NCT01814748,NCT00754403,NCT02956044,NCT04416269,NCT00959101,NCT00327015,NCT01334125,NCT04998032,NCT04581447,NCT00770445,NCT01192139,NCT01107717,NCT00770835,NCT03670043,NCT00684528,NCT00279240,NCT00969566,NCT02719756,NCT01046422,NCT00108615 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
CA4,MMP12,NR3C1,ALOX5
NCT01057615 |
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
FLT3,EGFR,SLC6A2,SLC6A4,KDR
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
MET,TK1,DPP4,HCAR2,TP53
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
ALOX5,KDR,AHR
NCT00272610,NCT01014546 |
Fragile X chromosomeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD55 |
GSK3B
NCT03862950,NCT04141163,NCT03479476,NCT03722290 |
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
DPP4
NCT00000541,NCT03516903,NCT00000482,NCT00120289 |
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
FLT3
NCT02815397,NCT03600363,NCT02531308,NCT03200015 |
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
SLC6A3
NCT02800161,NCT00322764,NCT00841269,NCT02519543 |
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
NCT00170404,NCT01785186,NCT01936831,NCT05215990,NCT02563327
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT00024310,NCT01566799,NCT03017833,NCT04428086,NCT01057589
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT04801511,NCT05378919,NCT03053544,NCT02437656,NCT02473094
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT03833466,NCT03076281,NCT02394652,NCT03618654,NCT02083692
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
NOX4,HCAR2,MMP9,MMP1,MMP12
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CA12,MMP2,HSD17B2,MMP9,CDK1
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CYP1A1,MMP9,CA9,MMP1,MMP12
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
ACHE,HCAR2,HSD17B2,MET,AXL
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
NOX4,TK1,AHR,MMP9,MMP12
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
MKNK1,CYP19A1,ESR2,IGF1R,CA12,CA9,NR3C1,CA4,SRC,MKNK2,CA2,ESR1,KDR,MET,CDK1,EGFR,AXL
NCT01627067,NCT02472353,NCT02360059,NCT04248998,NCT03192293,NCT01042379,NCT02488564,NCT01589367,NCT04300790,NCT04559308,NCT01266486,NCT01302002,NCT03175341,NCT03238495,NCT02506777,NCT04899349,NCT01310231,NCT00909506,NCT02028221,NCT01477060,NCT01980823,NCT03006172,NCT02506790,NCT01650506,NCT04143282,NCT00930579,NCT05053841 |
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
MMP9,AKR1B1,ABCG2,MMP1,NFKB1,CA2,NR3C1,ALOX5
NCT00578305,NCT05363917,NCT01711359,NCT02379091,NCT00299104,NCT01850680,NCT00950989,NCT01061736,NCT02930343,NCT04068246,NCT00965653,NCT02467504,NCT03172325,NCT00299130,NCT01217814,NCT02795299,NCT00266227,NCT02762838,NCT02504671,NCT01010581,NCT04196868,NCT02393378,NCT03028467,NCT00298272,NCT02293902,NCT03863405,NCT00243412,NCT01116141,NCT01405118,NCT02093026,NCT02833350,NCT01873443 |
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
NR3C1,SLC6A3,SLC6A2,SLC6A4
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
ACHE,SLC6A3,DRD1
NCT04220021 |
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
SLC6A3,SLC6A4,ADRA2B,SLC6A2
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
SLC6A2,NR3C1,SLC6A3,SLC6A4
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
MMP2,ESR1
NCT03090048,NCT03522922 |
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NR3C1
NCT03651895,NCT03989271,NCT01708278 |
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
SLC6A2,DRD1,SLC6A4,SLC6A3
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR,KDR,MET
NCT05468554 |
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
SRC,TP53,KDR,FLT3
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
NFKB1,NR3C1
NCT01995032,NCT02018731 |
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
KDR,MET,SRC
NCT00003667 |
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
NR3C1,IGF1R,APP
NCT02587741 |
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
NR3C1,SRC,TK1,ALOX5
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA4,CA2,CYP2C9,CA12
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
SLC6A2,SLC6A4
NCT00067899,NCT05452772 |
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
SRC,EGFR,TP53,AXL
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
SRC,TP53
NCT01188876,NCT00005025 |
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
ESR1
NCT01885013,NCT01118624,NCT02278965 |
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT00000161,NCT05062486,NCT02684578,NCT00000152
|
Iron deficiency anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A00 |
NCT02541708,NCT03188445,NCT03481790,NCT04268849
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT02279758,NCT02823691,NCT02254512,NCT02294006
|
Malignant neoplasm metastasis in male genital organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E06 |
NCT02516670,NCT01677897,NCT04925063,NCT04926155
|
Autosomal dominant polycystic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB81 |
NCT03764605,NCT04939935,NCT02656017,NCT02903511
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT04301336,NCT02981329,NCT00508989,NCT01703104
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
NCT02878265,NCT02699099,NCT00120822,NCT05236530
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT00000620,NCT00300352,NCT04907253,NCT03943459
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
HCAR2,TSHR,CYP1A1,CDK1
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
PIM1,CYP2C9,ADRA2B,TSHR
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FLT3,MET,AXL,FFAR1
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
MMP12
NCT03268733,NCT03086005,NCT00159536,NCT03008551,NCT02562664,NCT03674385,NCT02022007,NCT01775176,NCT00283816,NCT01482286,NCT00948402,NCT04867252,NCT03905941,NCT01581814,NCT03117517,NCT02086526,NCT01733459,NCT00151411,NCT00344851,NCT00466622,NCT02026869,NCT02498522,NCT00714233,NCT03981861,NCT04973891,NCT04113889,NCT02689843,NCT03229057,NCT03108963,NCT05394142,NCT02244567,NCT04852510,NCT03259919,NCT01622257 |
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
MAPK1,AOX1,AHR,IGF1R,EGFR,AXL,CDK1,CA4,YES1,CSNK2A1,GSK3B,NR3C1,APP,CA12,MET,KDR,SRC,MMP9,FLT3,TP53,AURKB,CDA,HIF1A,NFKB1,ALOX5,CA2,CA9,MKNK2,XDH,MKNK1,ESR1,PIM1,POLB,TK1
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
KDR,SNCA,MMP1,ALOX15,CSNK2A2,MMP12,CA7,FFAR1,TK1,AURKB,CA9,XDH,TYR,RECQL,DPP4,PIM1,LMNA,AOX1,AHR,HSD17B2,SULT1A1,EGFR,CDK1,CA12,HCAR2,ALOX5,DRD1,MMP9,SLC6A3,TDP1,FLT3,SRC,MET,AXL
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
ACHE,SNCA,CA2,MMP1,ALOX15,CA7,TK1,ABCG2,AURKB,CA9,XDH,POLB,RECQL,DPP4,PIM1,CISD1,CYP2B6,MMP2,LMNA,HSD17B2,CYP1B1,CYP2C9,HCAR2,APP,ALOX5,DRD1,HIF1A,MET,AXL,NPSR1
|
FatigueDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG22 |
SLC6A2
NCT00633581,NCT02521077 |
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
ESR1,FLT3
NCT04898023 |
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
ACHE,SLC6A2,MAPT
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
IGF1R,ESR1,ALOX5
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
FFAR1,FLT3,ALOX5
|
Menopausal disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA30 |
ESR2,ESR1,SLC6A4
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
ALOX5,XDH
NCT02735707 |
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
HCAR2,ESR1,ESR2
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
EGFR,KDR,MET
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
ESR2,NR3C1,NFKB1
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
NR3C1,DRD1
NCT02936830 |
Binge eating disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B82 |
SLC6A3,SLC6A2,SLC6A4
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
EGFR,ALOX5,CDK1
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
MET,EGFR
NCT01587261 |
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53
NCT00154700,NCT04648917 |
Corneal diseaseDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A76-9A78 |
SLC6A4,SLC6A2,SLC6A3
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
FLT3,SRC,GSK3B
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
MET
NCT00000600,NCT00807807 |
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA12,CA4,CA2
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
DPP4
NCT00325572,NCT00672360 |
Neurobehavioral disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00-8A0Z |
SLC6A4
NCT03479476,NCT03862950 |
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
NR3C1,ESR2,CYP19A1
|
Neuropathy, ataxia, and retinitis pigmentosaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C73.1 |
NCT00065455,NCT00000114,NCT00000116
|
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
NCT02369822,NCT02318446,NCT00004758
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT01550510,NCT01926769,NCT01725490
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA4
NCT00388856,NCT03451266 |
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT03047837,NCT04035096,NCT01440127
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT03866174,NCT04088448,NCT04630964
|
Cardiac arrestDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC82 |
NCT03450707,NCT04921189,NCT03509662
|
Vitamin C deficiency, unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B56.Z |
NCT03224572,NCT05009355,NCT02606773
|
Primary neoplasms of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
NCT02040376,NCT02149459,NCT01528046
|
Schizophrenia or other primary psychotic disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A2Z |
NCT00202280,NCT01720095,NCT04511416
|
Mixed hyperlipidaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.2 |
NCT00289900,NCT00269217,NCT00269204
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT04783792,NCT04767841,NCT05276895
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT02360618,NCT04046094,NCT03379909
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT02614859,NCT01561482,NCT02640534
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
MMP12,MMP9,DPP4
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
SLC6A4,ABCG2,CYP1B1
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
MET,HCAR2,MMP9
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
ACHE,KDR,HSD17B10,MMP1,AKR1B1,CSNK2A2,FFAR1,TK1,AURKB,CA9,RECQL,ESR2,NOX4,LMNA,MMP2,CISD1,AOX1,AHR,EGFR,CDK1,CA12,TSHR,TP53,TDP1,SRC,MET,AXL
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
ACHE,KDR,SNCA,MAPK1,MMP1,AKR1B1,CA4,ABCG2,SLCO1B1,XDH,DPP4,NOX4,CYP2B6,MMP2,AHR,ALOX12,HSD17B2,CYP2C9,CDK1,CA12,CDA,APP,ALOX5,DRD1,HIF1A,MET,NPSR1
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
SLC6A4,CA2,HSD17B10,CYP19A1,MMP1,AKR1B1,ALOX15,MMP12,CA7,FFAR1,CA9,XDH,POLB,DPP4,CISD1,CYP2B6,HSD17B2,YES1,HCAR2,TSHR,TP53,MMP9,TDP1,MET,AURKB,NPSR1
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
MAPT,CYP19A1,MMP1,MMP12,CA4,TK1,CA9,NOX4,SLC6A2,CDK1,CA12,MMP9,SLC6A3,AURKB,CA12,MAPT,SRC,TK1,MMP9,CYP19A1,CA9,MMP1,CDK1,MMP12,AURKB
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04395768,NCT04335084,NCT04446104,NCT04853199,NCT04347889,NCT05029037,NCT04328961,NCT04354428,NCT02735707,NCT04851821,NCT04631536,NCT03680274,NCT04928495,NCT04363216,NCT05283954,NCT04510194,NCT04357782,NCT04401150,NCT04344184,NCT04482686,NCT04334512,NCT04900415,NCT04370288,NCT04604678
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CA2,MMP1,ALOX15,MMP12,CA9,XDH,NOX4,CISD1,AHR,ALOX12,HSD17B2,YES1,CYP1A2,CA12,CDA,HCAR2,TSHR,ALOX5,CSNK2A3,TP53,MMP9,ESR1,TDP1,MET
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
MAPT,SLC6A4,MMP1,AKR1B1,MMP12,CA4,TK1,CA9,ESR2,NOX4,MMP2,LMNA,ALOX12,CDK1,ALOX5,HIF1A,CSNK2A3,TP53,MMP9,SLC6A3,SRC,IGF1R,AURKB
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
ESR2,NR3C1,AOX1,ESR1,AURKB,TK1
NCT00881725,NCT00268476,NCT05501548,NCT01705652,NCT02945813,NCT00216099,NCT01215032,NCT02497638,NCT04536805,NCT01864096,NCT02946996,NCT03137186,NCT03465345,NCT01733836,NCT01243385,NCT01620593 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
FFAR1,DPP4,NR3C1,NFKB1
NCT01217892,NCT00528372,NCT01217073,NCT03685773,NCT00961480,NCT00350779,NCT01023581,NCT00121667,NCT00856284,NCT00097500,NCT00544518,NCT00359112,NCT00454233,NCT00611884,NCT00976937,NCT00379769,NCT00875394,NCT02786823,NCT00643851,NCT00631488,NCT00715624,NCT00399711,NCT00420511,NCT01296412,NCT00798161,NCT00960076,NCT00856986,NCT03540758,NCT00881530,NCT00121641,NCT00086502,NCT00111631,NCT00468039,NCT01365091,NCT01302145,NCT00712673,NCT00975286,NCT00701090,NCT00525330,NCT00838903,NCT00131664,NCT01068743,NCT01089192,NCT01117584,NCT01357876,NCT00871936,NCT01383356,NCT00676338,NCT00614055,NCT01126580,NCT00575588,NCT00331851,NCT00698789,NCT00328172,NCT01240759,NCT00279045,NCT01089205,NCT00184574,NCT00900146,NCT00485758,NCT00541775,NCT01076075,NCT00763815,NCT01135433,NCT01068730,NCT01319734,NCT00915772,NCT00618995,NCT01332071,NCT00263276,NCT00968812,NCT00859898,NCT00106340,NCT01111955,NCT00672386,NCT00961909,NCT00754689,NCT01204294,NCT00103857,NCT01340664,NCT00792935,NCT00789191,NCT00069836,NCT00295633,NCT00266253,NCT00627445,NCT00961857,NCT00376038,NCT00383578,NCT00744367,NCT00449605,NCT00975052,NCT01289119,NCT00899470,NCT00333151,NCT01068717,NCT00427154,NCT00087516,NCT01089179,NCT00272064,NCT00316758,NCT00348712,NCT00528879,NCT01204775,NCT00261352,NCT01340768,NCT00839527,NCT00885352,NCT00081328,NCT00755287,NCT00318461,NCT00598793,NCT01076088,NCT00499707,NCT00353691,NCT00830076,NCT00102466,NCT00174642,NCT00763451,NCT01051011,NCT00960661,NCT00543361,NCT00097279,NCT00263965,NCT00482729,NCT01305551,NCT00700817,NCT01154348,NCT00605475,NCT01459809,NCT00414245,NCT00251953,NCT00067951,NCT01093794,NCT00396357,NCT01106690,NCT01353391,NCT00613951,NCT01211197,NCT03437902,NCT01059825,NCT00337610,NCT00767000,NCT01434186,NCT01095666,NCT00722371,NCT00481663,NCT00479466,NCT00086515,NCT00375388,NCT00469586,NCT01381900,NCT01002807,NCT00901979,NCT00814372,NCT00885378,NCT01368328,NCT01034111,NCT00000620,NCT00707031,NCT00728351,NCT00690456,NCT00614120,NCT00734474,NCT00851903,NCT00374907,NCT00918138,NCT01106677,NCT01839344,NCT00032487,NCT01095653,NCT00698230,NCT01245166,NCT00754988,NCT01137812,NCT01318109,NCT00519480,NCT01175473,NCT00789035,NCT01318135,NCT01368081,NCT00673465,NCT00571519,NCT00382096,NCT01064687,NCT00924573,NCT01462266,NCT01106625,NCT01075282,NCT00743002,NCT01169779,NCT00971659,NCT01396564,NCT00332488,NCT00855166,NCT01292993,NCT00971243,NCT00713830,NCT00783744,NCT00110851,NCT00099866,NCT00425009,NCT01089166,NCT00860288,NCT00868790,NCT01071850,NCT01028391,NCT01472367,NCT00661362 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
MKNK2,KDR,EGFR,MKNK1,FLT3,IGF1R,TP53,MET
NCT00973609,NCT01816659,NCT04337879,NCT04516681,NCT02066688,NCT00096330,NCT00070434,NCT00002650,NCT02969681,NCT02614339,NCT00611000,NCT01426490,NCT01632020 |
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
SNCA,CYP19A1,MMP1,MMP12,CA7,FFAR1,CA4,TK1,CA9,DPP4,NOX4,HSD17B2,SLC6A2,CDK1,CA12,NR3C1,MMP9,SLC6A3,MET,AURKB
|
Vitamin deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B55-5B5F |
AOX1,NR3C1
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CYP19A1,AKR1B1
|
Motor neuron diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60 |
IGF1R,SRC
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1,NR3C1
|
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
NR3C1,ESR2
|
Orthostatic hypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA21 |
SLC6A2,SLC6A4
|
Gastrointestinal stromal tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5B |
KDR,SRC
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
SLC6A2,HIF1A
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3,TK1
|
Malignant digestive organ neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C11 |
SRC,KDR
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
AKR1B1
NCT00000161 |
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
EGFR,SRC
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
ESR1,CA2
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
CDK1,FLT3
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
ESR2,EGFR
|
Adrenal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
ESR1,SLC6A2
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
SLC6A4
NCT00763633 |
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
SLC6A4,SLC6A2
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
FLT3,SRC
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
ESR1,CYP19A1
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NR3C1
NCT00133419 |
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
MMP9
NCT00120289 |
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
NFKB1,ALOX5
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
ABCG2,NFKB1
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
NFKB1,MAPT
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
SLC6A4,CA2
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
GSK3B,SRC
|
CoughDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD12 |
SLC6A4
NCT01119534 |
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
EGFR
NCT01710527 |
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
MMP9
NCT04750135 |
Soft tissue disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB56 |
SLC6A4
NCT03508726 |
Stomach diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA43-DA4Y |
SLC6A3,SLC6A2
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
HCAR2
NCT00796887 |
FlushingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME64.4 |
NCT00536237,NCT00533611
|
Upper respiratory tract disorderDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0Z |
NCT02730364,NCT02678234
|
Acute viral hepatitisDisease Category: NADisease ICD-11 Code: NA |
NCT03000218,NCT00063232
|
Cerebrovascular diseases, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B2Z |
NCT00000600,NCT00000599
|
Huntington diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01.10 |
NCT04826692,NCT04478734
|
Endometrial glandular hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA16.0 |
NCT01685762,NCT04607252
|
AsphyxiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD11.1 |
NCT03066115,NCT04357782
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT02186158,NCT02735707
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT02702492,NCT00626444
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT01891747,NCT01502280
|
Asymptomatic stenosis of intracranial or extracranial arteryDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD55 |
NCT00000599,NCT00000600
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT02793648,NCT00480207
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT03541486,NCT01852890
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
NCT04261036,NCT03800667
|
Spina bifida, unspecifiedDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA02.Z |
NCT00452829,NCT00301587
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
NCT03600363,NCT00455416
|
Sex development malformative disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2A |
NCT03862950,NCT03479476
|
Cleft palateDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA42 |
NCT00397917,NCT00098319
|
Disorders of intellectual development, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A00.Z |
NCT03862950,NCT03479476
|
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT05305898,NCT00855257
|
Peripheral T-cell lymphoma, not otherwise specifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.C |
NCT02106650,NCT02013362
|
Other specified non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.Y |
NCT00063635,NCT00303537
|
Cleft lipDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA40 |
NCT00098319,NCT00397917
|
ConstipationDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.0 |
NCT01335386,NCT01474499
|
Other specified infectious meningitis not elsewhere classifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.Y |
NCT03101579,NCT05289908
|
Symptoms and signs involving cognition, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.Z |
NCT00620191,NCT04098666
|
Impaired glucose toleranceDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A40.1 |
NCT01234649,NCT02621060
|
Retinal vascular occlusionDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74 |
NCT00500045,NCT00493064
|
Oral mucositisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01 |
NCT02868151,NCT03581773
|
Insulin-resistance syndromesDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A44 |
NCT04264897,NCT04148183
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT02819869,NCT02672488
|
Aneurysm/dissectionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD50 |
NCT04500756,NCT04224051
|
Burn and burn infectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND90-NE2Z |
NCT00734695,NCT04530058
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT01188876,NCT00005025
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04510194,NCT04482686
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
ACHE,AXL
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
AURKB,ABCG2
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
CA4,ABCG2
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
NOX4,MMP1
|
Malaria, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F4Z |
HCAR2,MMP9
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
AXL,FLT3,AHR,KDR,SRC,IGF1R
NCT02206425,NCT00469209,NCT03964688,NCT00258245,NCT00227682,NCT00085345,NCT00006021,NCT00317811,NCT02967276,NCT00112879,NCT00661544,NCT03602235,NCT02114502 |
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
EGFR,MET,KDR
NCT02905591,NCT03086733,NCT00609518,NCT00806819,NCT03799094,NCT05096663,NCT02019979,NCT04170959,NCT01864681,NCT00606502,NCT01717482,NCT02420314,NCT01194453,NCT01997775,NCT02655913,NCT01165021 |
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
MAPT,ACHE,HSD17B10,NFKB1,AKR1B1,ALOX15,MMP12,CA9,DPP4,CISD1,HSD17B2,CYP1B1,CYP2C9,SLC6A2,HCAR2,DRD1,MMP9,SLC6A3,FLT3
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
EGFR,MMP12,IGF1R,CDK1,FLT3,KDR,AXL,MMP2,MMP1,MMP9,ALOX5,MET
NCT00402883,NCT02285855,NCT00210080,NCT00033722,NCT02115464,NCT03751592 |
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
ACHE,CYP19A1,CA9,XDH,TYR,CYP2C9,ALOX5,MMP9,MET,AURKB,TSHR,ALOX5,MMP9,SLC6A3,CA9,MMP1,MMP12,AURKB
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
ACHE,MMP1,MMP12,CA7,TK1,SLCO1B1,CA9,XDH,CYP2B6,CYP2C9,CDK1,CA12,CDA,TSHR,MMP9,SLC6A3,AURKB,NPSR1
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
HCAR2
NCT00664287,NCT00626392,NCT02890992,NCT01984073,NCT01104519,NCT00944645,NCT00376584,NCT00111891,NCT01071291,NCT00903617,NCT00943124,NCT00961636,NCT00361868,NCT00630877,NCT03510884,NCT00728910 |
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
MMP1,MMP12,CA7,TK1,SLCO1B1,CA9,XDH,ALOX12,CYP2C9,SLC6A2,CDK1,CA12,TSHR,ADRA2B,MMP9,AURKB,NPSR1
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
SLC6A3,SLC6A2,SLC6A4
NCT01677923,NCT04839237,NCT03000218,NCT02063802,NCT01083329,NCT00631033,NCT00842400,NCT01725126,NCT00892073,NCT00120146,NCT00349635,NCT03349775,NCT00941382 |
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
SLC6A4,CYP19A1,MMP1,AKR1B1,MMP12,CA4,TK1,NOX4,MMP2,SLC6A2,CDK1,CA12,MMP9,SRC,IGF1R,AURKB
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CA2,CYP1A1,MMP1,ALOX15,MMP12,TK1,AURKB,CA9,XDH,CYP2B6,HSD17B2,CYP2C9,CDK1,HCAR2,MMP9,NPSR1
|
HypercholesterolaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.0 |
NCT01054508,NCT03510715,NCT00378833,NCT00080275,NCT00271817,NCT01321034,NCT00203476,NCT00652431,NCT00269217,NCT00082251,NCT00769132,NCT00000620,NCT01071525,NCT00536510,NCT00533312
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
MAPT,ACHE,SNCA,CA2,MMP1,MMP12,CA4,XDH,NOX4,SLC6A2,NR3C1,CDA,APP,MMP9,MET
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
ACHE,NOX4,TK1,CYP2B6,CDA,MMP9,SLCO1B1,AURKB,SLC6A2,MMP1,CDK1,MMP12,ALOX15,NPSR1
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00441207,NCT00957359,NCT02136342,NCT00441870,NCT01050621,NCT01983969,NCT01529593,NCT02245204,NCT01562626,NCT01442870,NCT00034463,NCT01087983,NCT04733534
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT03151772,NCT03243851,NCT02833701,NCT01752491,NCT04945148,NCT02780024,NCT04677049,NCT02344355,NCT04900792,NCT04691960,NCT05183204,NCT02728349,NCT03758014
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
CYP19A1,MMP1,ALOX15,MMP12,SLCO1B1,NOX4,CDK1,DRD1,MMP9,SLC6A3,MET,AURKB,NPSR1
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
TK1,CA2,CYP2B6,MMP9,SLCO1B1,CA9,SLC6A2,CYP2C9,MMP1,AKR1B1,CDK1,AURKB,CYP1A2
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CA12,NOX4,HCAR2,CDA,DPP4,ALOX5,CYP1B1,XDH,MMP1,MMP12,MET,CA7,FFAR1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
KDR,CA2,CYP19A1,CA9,DPP4,LMNA,AOX1,CYP1B1,CA12,HCAR2,TSHR,CSNK2A3,MET
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
AXL,NFKB1,FLT3,PIM1,GSK3B,AURKB,TP53,SRC,MAPT,TK1
NCT00329498,NCT00184054 |
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
DPP4
NCT01234649,NCT04817787,NCT01046500,NCT02773927,NCT00362323,NCT00348725,NCT02629627,NCT00300365,NCT00703755,NCT00349128,NCT02778776 |
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
MMP1,MMP12,TK1,SLCO1B1,CA9,NOX4,SLC6A2,MMP9,AURKB,NPSR1
NCT02949700,NCT04414540 |
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
SLC6A4,MMP1,MMP12,TK1,CA9,CYP2B6,CDK1,CA12,MMP9,ESR1,AURKB
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
MKNK2,CA9,MKNK1,HIF1A,EGFR
NCT00998946,NCT02961816,NCT01983969,NCT02701673,NCT02589145 |
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
KDR,SRC,TP53,MMP2,EGFR,MET,ESR1,MMP9,HIF1A,MMP1
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
IGF1R,XDH
NCT02791906,NCT02895750,NCT05373680,NCT02947750,NCT05284656,NCT02848508,NCT01356966,NCT02848131 |
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
KDR,SNCA,SLC6A4,MET,ESR2,APP,FLT3,ACHE,MAPT
NCT00056225 |
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
SRC,MET,KDR,FLT3,TP53
NCT00005025,NCT00284427,NCT01188876,NCT03378297,NCT02312661 |
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
CYP1A1,MMP1,MMP12,SLCO1B1,CA9,TYR,NOX4,HCAR2,MET,NPSR1
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
ACHE,KDM4E,CA2,CYP1A1,ADRA2B,MMP9,CYP2C9,SLC6A2,ALOX15,ESR2
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA,MMP2,HIF1A,ADRA2B,CYP19A1,EGFR,SLC6A2,XDH,AXL,FFAR1
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
SLC6A4,CA2,CYP1A1,SLC6A2,CYP1A2,CA12,CDA,HCAR2,MET,AURKB
|
Other specified disorders of carbohydrate absorption or transportDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C61.Y |
NCT02330341
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
SRC
|
NarcolepsyDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A20 |
SLC6A3
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
EGFR
|
Carcinoid syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B10 |
ALOX5
|
DyslipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80-5C81 |
HCAR2
|
Intracranial injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07 |
SLC6A3
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
MMP2
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
NR3C1
|
Adrenogenital disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A71 |
NR3C1
|
VaginitisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA02 |
ESR1
|
Adaptive immunity immunodeficiencyDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01 |
NR3C1
|
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
CA2
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
|
Spine/trunk injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51 |
NR3C1
|
Metastatic malignant neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E09 |
AXL
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
NFKB1
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
EGFR
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3
|
Metastatic tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E2Z |
ESR1
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
|
Ureteral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C92 |
AHR
|
DyspareuniaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA12 |
ESR1
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
SRC
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NFKB1
|
Multiple structural anomalies syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F |
IGF1R
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
Oesophageal/gastroduodenal disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD90 |
ACHE
|
FilariasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F66 |
ALOX5
|
Skeletal anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD24 |
ESR1
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TP53
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
DRD1
|
AmyloidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5D00 |
APP
|
Acute painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG31 |
SLC6A2
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
ACHE
|
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3
|
Prostate hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA90 |
ESR2
|
Liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90-DB9Z |
MET
|
Digestive organ benign neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E92 |
KDR
|
ZosterDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E91 |
TK1
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
NFKB1
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
SLC6A4
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
|
Epidermal dysplasiasDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK90 |
SRC
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MAPK1
|
Acquired prion diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E01 |
ESR1
|
Unspecific substance harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE6Z |
ACHE
|
Autonomic nervous system disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D87 |
SNCA
|
Synovial sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5A |
SRC
|
Female infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA31 |
ESR1
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
FLT3
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
CA2
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
ESR1
|
AbortionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA00 |
DRD1
|
Metastatic biliary tract neoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C14-2C17 |
EGFR
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
EGFR
|
Dystrophic epidermolysis bullosaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EC32 |
APP
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
FLT3
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Diagnostic imagingDisease Category: NADisease ICD-11 Code: N.A. |
APP
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
EGFR
|
Female genital tract noninflammatory disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA1Y |
ESR1
|
Acquired hypermelanosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED60 |
TYR
|
Parasitic worm infestationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F90 |
ACHE
|
Spinal cord/cranial nerve neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A02 |
EGFR
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
TYR
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
EGFR
|
Tic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A05 |
DRD1
|
Menstrual cycle bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20 |
ESR1
|
Desmoid tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7C |
APP
|
ThyrotoxicosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A02 |
IGF1R
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Extraocular muscle disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C82 |
IGF1R
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
|
PediculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G00 |
ACHE
|
Myotonic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71 |
GSK3B
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
MET
|
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
EGFR
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
EGFR
|
Ejaculatory dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA03 |
SLC6A4
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
AKR1B1
|
Skin postprocedural disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EL8Y |
EGFR
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
TP53
|
concerning food/fluid intake symptomDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG43 |
SLC6A4
|
Polycythaemia veraDisease Category: X.Extension CodesDisease ICD-11 Code: XH0453 |
NCT01014546
|
Postpartum haemorrhageDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA43 |
NCT02424201
|
Sezary syndromeDisease Category: X.Extension CodesDisease ICD-11 Code: XH8HN3 |
NCT01134341
|
GliosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9RC8 |
NCT02168270
|
Infectious gastroenteritis or colitis without specification of infectious agentDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A40.Z |
NCT00133406
|
Lichen planusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA91 |
NCT01375101
|
Movement disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A07-8A0Z |
NCT01908452
|
Diseases of the visual system, unspecifiedDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9E1Z |
NCT00243711
|
MenopauseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA30.0 |
NCT00000555
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT04780854
|
MyelofibrosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A22 |
NCT01014546
|
Generalised anxiety disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B00 |
NCT00809536
|
Infantile spasmsDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62.0 |
NCT01828437
|
Congenital aplastic anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A70.0 |
NCT01720147
|
Noninfectious erosive or ulcerative disorders of oral mucosaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.1 |
NCT04989049
|
Anaplastic large cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1LC0 |
NCT01134341
|
Macro reentrant atrial tachycardia, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.2Z |
NCT00953212
|
Hidradenitis suppurativaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED92 |
NCT04649502
|
Allergic conjunctivitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A60.02 |
NCT00841256
|
Pulmonary alveolar proteinosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB04.31 |
NCT03887169
|
Parasitic infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D0Y-1G2Z |
NCT00396500
|
Squamous cell carcinoma of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.0 |
NCT03618654
|
Basal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C32 |
NCT04279535
|
Hereditary sensory or autonomic neuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C21.Z |
NCT00271635
|
Bacterial meningitisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.0 |
NCT00619203
|
Atherosclerotic chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD40.Z |
NCT00804843
|
Migraine disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SD10 |
NCT02593097
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT01348204
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
NCT03015675
|
Acute promyelocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1A50 |
NCT03624270
|
Oligodendroglioma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH8844 |
NCT02168270
|
Cutaneous T-cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1951 |
NCT00554827
|
Vitamin A deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B55 |
NCT00128557
|
Injury of lung, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NB32.3Z |
NCT04344184
|
Disorders of muscles, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB3Z |
NCT03223519
|
Malignant neoplasms of other or unspecified parts of mouthDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B66 |
NCT05456022
|
Diabetic polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C03.0 |
NCT00634998
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT01324180
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT02437812
|
Secondary progressive multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.2 |
NCT05349474
|
Urogenital cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C95-2C9Z |
NCT02365597
|
AnorexiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG43.7 |
NCT01295450
|
Harmful effects of drugs, medicaments or biological substances, not elsewhere classifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE60 |
NCT02908581
|
Astrocytoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH96C7 |
NCT02168270
|
Diabetic lactic acidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A22.1 |
NCT00143702
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT01750567
|
Acute pancreatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC31 |
NCT02110810
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT01426438
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT01436266
|
Aortic valve stenosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB70 |
NCT02109614
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01438320
|
Duchenne muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70.1 |
NCT02516085
|
Tuberculosis of the respiratory systemDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10 |
NCT03882177
|
Other specified syndromes with multiple structural anomalies, not of environmental originDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F.1Y |
NCT00446147
|
Complex regional pain syndromeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.04 |
NCT02390505
|
Central diabetes insipidusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A61.5 |
NCT02460354
|
Columnar metaplastic epithelium of the oesophagus, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA23.Z |
NCT01465113
|
Post-traumatic stress disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B40 |
NCT03752918
|
AngiosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B56 |
NCT01042379
|
Immune thrombocytopenic purpuraDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64.10 |
NCT02351622
|
Neuropathic painDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43.0 |
NCT00971295
|
Duplications of the short arm of chromosome 17Disease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD41.G1 |
NCT00484510
|
ShockDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG40 |
NCT01587963
|
Obstructive sleep apnoeaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A41 |
NCT04530747
|
Primary progressive multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.1 |
NCT05349474
|
Mild hyperemesis gravidarumDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA60.0 |
NCT00861523
|
Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30 |
NCT03418038
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT03994744
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
NCT04404387
|
Unspecified undernutritionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B7Z |
NCT00396500
|
Osteosarcoma of bone and articular cartilage of other specified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51.Y |
NCT01981525
|
Respiratory failureDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB41 |
NCT01985685
|
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT03054519
|
Uterine fibroidDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E66 |
NCT01715597
|
Lipoatrophy/lipodystrophyDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EF01 |
NCT00362440
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT04055012
|
Chronic kidney disease, stage unspecifiedDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61.Z |
NCT00136188
|
Spastic cerebral palsyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D20 |
NCT03710343
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
NCT02044341
|
Clear cell renal cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH46F1 |
NCT03334409
|
Anterior uveitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A96 |
NCT01900431
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
NCT00401973
|
Large cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.3 |
NCT02186847
|
LeprosyDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B20 |
NCT05243654
|
Pleural mesotheliomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26 |
NCT01569919
|
HypopituitarismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A61.0 |
NCT03490019
|
Gastro-oesophageal reflux diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA22 |
NCT02226484
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT03056274
|
Adenocarcinoma, endocervical typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GS9 |
NCT02394652
|
Recurrent pregnancy lossDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA33 |
NCT01976676
|
Temporomandibular joint disordersDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0E.8 |
NCT02602483
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT01953536
|
Mycosis fungoidesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B01 |
NCT01134341
|
Beta thalassaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A50.2 |
NCT02083575
|
Cannabis use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C41 |
NCT05432284
|
BlindnessDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9D90.6 |
NCT03490019
|
Malignant neoplasms of ill-defined sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
NCT03477162
|
Obsessive-compulsive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B20 |
NCT03356483
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT01840007
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
MMP12
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
CA4
|
Dilated cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.0 |
ABCG2
|